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ABSTRACT 
 
 
Background: Accurate measurement of RBCs (red blood cells) by automated hematology 
analyzers such as the ADVIA 120/2120 requires isovolumetric cell sphering; however, camelid 
RBC membranes are resistant to shape change.  There are no published reports of method 
validation for hematologic analysis of camelid blood.  Mycoplasma haemolamae and 
gastrointestinal nematodes can cause anemia in camelids. Parasite control programs aim to 
suppress parasite loads without promoting resistance, but there are few evidence-based 
guidelines for acceptable parasite loads in camelids.   
Objectives: 1) Demonstrate whether camelid RBCs sphere in the ADVIA sphering reagent, and 
determine the optimal ADVIA setting for CBC (complete blood count) analysis, 2) Compare M. 
haemolamae PCR status with RBC values, and 3) Determine the fecal egg count (FEC) threshold 
above which RBC values are consistently below the median of the reference interval.   
Methods: Camelid and canine blood were each added to ADVIA sphering reagent or saline, and 
evaluated by light microscopy for erythrocyte sphering.  Camelid blood was analyzed on an 
ADVIA 120 hematology analyzer using one of three species settings, and values compared to 
manual measurements, including packed cell volume (PCV), Z2 Coulter counter RBC count, and 
calculations of other RBC values.  Mycoplasma haemolamae was detected by real-time PCR.  The 
number of trichostrongyle eggs per gram (epg) of feces was determined using the Modified 
McMaster’s test.   
Results and Conclusions: Camelid erythrocytes do not sphere when mixed with ADVIA sphering 
reagent.  The ADVIA 120 equine setting provides the closest approximations to Z2 counter RBC 
count estimates, but ADVIA results for most other RBC values appear inaccurate.  PCV, 
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hemoglobin, and RBC count are not significantly different between M. haemolamae positive and 
negative animals, but are significantly lower in animals with FEC> [greater than] 600epg.  For all 
animals with FEC>600epg, RBC values are below the medians of the reference intervals.  Positive 
M. haemolamae PCR is not associated with lower RBC values in healthy camelids, consistent 
with previous reports that most infections are subclinical.  Maintaining FEC below 600 epg is 
recommended in camelids.  
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INTRODUCTION  
 
Camelid RBC structure and function 
Overview 
Camelid species, including the camel (Camelus dromedarius and C. bactrianus), llama (Lama 
glama), alpaca (Vicugna pacos), vicuña (Vicugna vicugna), and guanaco (Lama guanicoe), have 
erythrocytes that are unique in shape, size, and biochemical composition compared to those of 
other mammalian species, including humans.  In contrast to the biconcave disc shaped RBCs of 
most mammalian species, camelid RBCs are elliptical and flat, and have a smaller volume than 
those of many other animals.1-4  Additionally, camelid RBCs are rigid, less deformable, and less 
susceptible to osmotic lysis than those of other mammals.2,4,5  Deformability, or the ability of a 
cell to change its shape without breaking, is typically considered a beneficial feature for RBCs as 
they flow through vessels of varying size (large arteries to small capillaries), and are subjected to 
shearing stresses in flowing blood.6  In human patients with hereditary elliptocytosis as a result 
of various RBC membrane protein deficiencies, a diagnostic hallmark of the disease is RBC 
fragmentation secondary to decreased deformability.7  A report of canine elliptocytosis also 
documented both decreased deformability and decreased mechanical stability of RBC 
membranes in the proband compared to a healthy control dog, although RBC fragmentation was 
not sufficient to cause clinically significant hemolysis in this case.8  However, the flat, elliptical 
shape and rigidity of the camelid RBC appear to offer physiologic benefits for these animals, 
likely by providing increased effective surface area for gas exchange (important in high altitude 
environments with low oxygen tension), and by increasing the cells’ resistance to osmotic lysis 
(important in arid environments where water is rapidly consumed in large volumes when it is 
found).4  The potential problem of fragmentation as an elliptical, relatively non-deformable cell 
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passes through small capillary beds appears to be averted in these species as a result of their 
small cell size.4   
Studies of camelid RBCs 
Camelid RBCs have been the subject of intensive study by both clinical and basic scientists due 
to their unique physical and biochemical properties.  The elliptical shape of camelid RBCs on 
stained blood films was first described in 1875,9 and approximately 100 years later the scanning 
electron microscope (SEM) provided a three-dimensional image of these cells, which multiple 
authors have described as “thin and wafer-like.”10,11  SEM images of both camel and llama 
erythrocytes mixed with human erythrocytes showed that camelid RBCs are both smaller and 
flatter than human RBCs.12  The author of the same study also concluded that camelid RBCs have 
a higher concentration of hemoglobin within their smaller volumes, based on a higher relative 
mean corpuscular hemoglobin concentration (MCHC) compared to that of human RBCs analyzed 
with the same method.12  This finding has also been described in more recent reviews of camelid 
hematology.2  In 2005, Bogner, et al. demonstrated that camel erythrocytes have similar water 
to protein dry mass ratio as dehydrated human erythrocytes.13  Given that water-protein 
interactions increase the osmotically non-responsive fraction of water within the cell, an 
increased protein (hemoglobin) concentration within camelid erythrocytes may contribute to 
the decreased rate of diffusion of water out of the cells, consequently increasing their resistance 
to dehydration relative to human erythrocytes.13  The same group of researchers suggested that 
although the concentration of water in camel and llama erythrocytes is lower than that of 
normal human RBCs, the osmotically non-responsive (protein-bound) fraction of water is 
actually higher, possibly due to increased numbers of charged amino acid residues on their 
hemoglobin molecules, increasing the hydrophilicity of camelid hemoglobin.14  The combination 
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of increased hemoglobin water affinity and cellular hemoglobin concentration in camelid RBCs 
may therefore reflect an adaptive resistance to osmotic dehydration in arid environments.13,14   
The high water-binding capacity of camelid RBCs may also make them more resistant to over-
hydration, as might occur after rapid consumption of a large volume of water following a period 
of dehydration.  Camel RBCs have been shown to expand their volume up to 196% with 
exposure to hypotonic saline prior to lysing (low osmotic fragility), despite the general trend of 
increasing osmotic resistance with increasing cell volume among other domestic animals.15  In 
an SEM study of camel RBCs following experimental dehydration and rehydration, minimal 
changes were observed in RBC size and shape, and manual hematocrit and refractometric 
plasma protein measurements changed by less than 5% over the course of the study, suggesting 
a mechanism of rapid equilibration of water between intracellular and extracellular 
compartments.16 
 
In addition to intracellular differences in hemoglobin structure and concentration, camelids also 
exhibit differences in their RBC membrane structure and protein composition compared to 
other domestic mammal species.  While camel RBC membranes have similar lipid composition 
relative to those of humans and other mammals, the overall ratio of proteins to lipids in the RBC 
membranes is increased (approximately 3:1).17  Additionally, while camel RBCs appear to have 
similar membrane proteins as those described in humans, the distribution and relative 
proportions of these proteins differ between the species.  Gel electrophoresis studies of 
extracted membrane proteins show that camel RBCs have identifiable bands comparable to 
human peripheral membrane proteins (spectrins) and integral membrane proteins (band 3, 
band 5, etc).  However, the peripheral membrane protein bands are smaller and the integral 
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membrane protein bands (especially band 3) are more distinct and appear to predominate.17  
This study also demonstrated that the integral membrane proteins are more closely organized in 
the camel RBC membrane, compared to the peripheral membrane proteins which have a similar 
concentration per unit of surface area as those in the human RBC membrane.  These authors 
suggested that the interactions of these integral membrane proteins contribute to increased 
mechanical stability of camel RBCs (observed in response to sonication).  Furthermore, 
reversibility of these protein interactions might allow for the dynamic swelling (vs. lysis) of the 
membrane that has been observed in response to plasma hypotonicity.15,17  Mechanical stability 
has also been demonstrated in the form of decreased deformability of camel RBCs when 
exposed to fluid shear stresses.  In contrast to the erythrocytes of most other domestic mammal 
species, which deformed readily under shear stress, camel (and llama) erythrocytes did not 
deform but became oriented in the direction of the fluid flow.18    
 
Additional work with camel and alpaca erythrocytes suggest that RBC membrane stability in 
these species is at least partially due to interactions between band 3 and peripheral membrane 
proteins such as ankyrin and protein 4.1, as removal of these proteins as well as the cytoplasmic 
portion of band 3 resulted in increased rotational mobility of band 3 (decreased structural 
organization within the membrane).19  Studies using llama erythrocytes have resulted in similar 
findings, namely that there is a 2.5-3x higher concentration of band 3 in camelid RBC 
membranes compared to human RBCs as a consequence of decreased relative surface area 
between the species (the absolute number of band 3 proteins is similar).20  The mechanical 
benefit of this higher concentration of integral membrane proteins seems appropriate, however 
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the physiologic significance of having an increased concentration of this anion transport protein 
is uncertain.20         
 
Camelid erythrocytes have decreased water content, increased resistance to osmotic and 
mechanical lysis, and decreased deformability, features which are important for life in arid 
environments.  However, these animals are also adapted to high altitude environments as a 
result of increased oxygen affinity of their RBCs relative to other mammalian species.  This high 
RBC oxygen affinity has been documented in all camelid species (wild and domestic), regardless 
of whether the animals are currently living at high altitudes, suggesting that it is an intrinsic 
characteristic of the Camelidae family.  Increased oxygen affinity in this family appears to be 
secondary to amino acid substitutions in hemoglobin that limit its binding to 2,3-
diphosphoglycerate (2,3-DPG), the primary molecule responsible for decreasing in vivo 
hemoglobin oxygen affinity.21,22  Adult alpacas also retain higher proportions of fetal hemoglobin 
molecules than adult animals of other species, which have higher affinity for oxygen than adult 
hemoglobin molecules.4      
Automated hematology analysis as it relates to camelid RBCs 
Several of the unique structural features of camelid RBCs described above contribute to 
adaptation to life in arid and/or high altitude environments, however these same features also 
pose challenges for accurate hematological analysis of camelid blood.    
Problem 1: The true volume of camelid RBCs is unknown 
Despite all of the work that has been done to characterize the structure and molecular 
composition of camelid erythrocytes, the true volume of these cells is not known.  This is an 
issue because all modern hematology analyzers, both electrical impedance and optical flow 
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cytometer based systems, determine cell counts in part by user-determined cell volume 
thresholds.23  The first step in obtaining accurate automated RBC counts is therefore to know 
the expected cell volume of the species being analyzed.  Automated flow cytometry analyzers 
are capable of directly measuring the volume of individual RBCs, 23-25 however this methodology 
is dependent on specific changes in cell shape that may not be observed in camelid RBCs as a 
consequence of their unique structural features (see below).   
 
Manual methods for estimating mean RBC volume in a whole blood sample have been utilized 
to validate automated hematology methods in several species. 24,26,27  In most species, manual 
mean cell volume (MCV) calculations involve obtaining a RBC count from a validated method 
(i.e. counts from a hemacytometer or particle counter) and dividing this by the packed cell 
volume (PCV) of the blood sample obtained by simple centrifugation.  Manual estimates of MCV 
in camelids have been reported, with the most recent studies providing reference intervals of 
21-28 fL for alpacas and 21-31 fL for llamas, although these are still rather imprecise 
approximations.3,28-30  Compared to other common domestic mammals such as the dog, the 
estimated camelid MCV range is lower.  However, this finding is consistent with the results of 
visual side by side comparisons of camelid and human RBCs, in which the camelid cells appear 
consistently smaller in overall dimensions (length, width, and depth).12 
Problem 2: Optical hematology analyzers use the Mie theory of light scatter to 
measure cell volume 
The majority of automated hematology analyzers currently used in veterinary clinics and 
reference laboratories utilize flow cytometry to measure and differentiate blood cells.  In flow 
cytometers, cells suspended in fluid pass single file through a narrow laser beam, and the cells 
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are identified and counted based on how they scatter light from the laser.23  In the ADVIA 120 
and 2120 hematology systems used in the present study, the two primary light scatter 
measurements for RBCs are low-angle (2-3o) and high-angle (5-15o) scatter, which translate into 
cell volume (in fL) and hemoglobin concentration (in g/dL), respectively.25  The analyzer’s 
interpretation of these low-angle and high-angle light scatter measurements is based on the 
mathematical principle of Mie theory, which works on the key assumption that the cell is a 
perfect sphere with homogeneous volume and refractive index.24,25    
 
In the ADVIA 120/2120, before the RBCs interact with the laser beam, they are first exposed to 
the ADVIA RBC/PLT reagent, which is a proprietary combination of sodium dodecyl sulfate and 
glutaraldehyde fixative.  This reagent interacts with the plasma membrane to convert the RBCs 
(and platelets) in the blood sample into isovolumetric spheres so that accurate direct volume 
and hemoglobin concentration measurements can be made for individual cells as they pass 
through the laser.  These individual measurements are then averaged by the analyzer to provide 
the MCV and CHCM (corpuscular hemoglobin concentration mean) indices commonly used by 
clinicians when evaluating RBC disorders.25  MCHC (mean corpuscular hemoglobin 
concentration) is another RBC index that is often used interchangeably with CHCM, although 
this value is calculated by the analyzer rather than derived from direct cell measurements.   
 
Flow cytometry analyzers have been validated for several domestic animal species, and 
veterinary software is available with pre-set volume and hemoglobin concentration (HC) 
thresholds for a variety of species on the ADVIA.31,32  However, there is evidence to suggest that 
camelid RBCs may not exhibit the deformability necessary to be transformed into isovolumetric 
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spheres by the ADVIA’s RBC/PLT reagent.  Khodadad, et al. performed a study in 1983 in which 
llama and human erythrocytes were exposed to a variety of conditions, including 
hyperosmolarity, ATP (adenosine triphosphate) depletion, and mixture with a non-ionic 
detergent.  While human RBCs exhibited marked alterations in morphology in each of these 
scenarios, the llama RBCs remained essentially unchanged on SEM imaging, retaining their flat 
elliptical shape.20  A separate study performed by Omorphos, et al. in 1989 also showed that 
camelid RBCs are resistant to shape changes induced by various drugs and metabolic conditions 
in RBCs of humans, and those of another artiodactyl outside of the Camelidae family (oryx).5  In 
both studies, the resistance of the camelid erythrocytes to shape change was attributed to 
structural differences in their cell membranes, as described in the preceding section.  To date, 
no research has been published to demonstrate a specific resistance to sphering by the RBC/PLT 
reagent, however based on these previous studies it seems highly unlikely that camelid RBCs 
would undergo this shape change.   
 
Given that the analyzer’s direct volume and HC measurements are dependent on light scatter 
properties of a homogeneous sphere, the ADVIA’s MCV and MCHC indices are likely to be 
inaccurate for camelids, although it is unclear exactly how they would be affected.  Various 
studies have been performed in an attempt to document the light scatter properties of 
ellipsoids33 and non-spherical RBCs in different orientations,34 and a “straight-ray 
approximation” has been proposed as an alternative method of volume measurement for non-
spherical RBCs.35  However, this information is still in the realm of basic physics, and is not 
currently practically applicable to the analysis of large numbers of RBCs in a patient sample. 
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The inaccuracies of MCV and MCHC values from automated analyzers have been documented in 
dehydrated human RBCs, and in human patients with decreased deformability of their RBCs.36,37 
In one of these studies, the use of an optical hematology analyzer on dehydrated RBCs resulted 
in an overestimation of MCHC and an underestimation of MCV.  The authors acknowledged that 
inadequate sphering of the RBCs in these samples likely contributed to inaccurate 
measurements, and cautioned against interpreting RBC size and hemoglobin concentration 
based solely on automated measurements, recommending calculation of these values from a 
manual PCV instead.37  Similar observations have been made in human patients with sickle cell 
anemia, in which irreversibly sickled RBCs exhibit decreased deformability (and likely incomplete 
sphering) as a consequence of polymerized abnormal hemoglobin bound to band 3 membrane 
proteins.38  Hemograms from these individuals show a broader range of cell volume and 
hemoglobin concentration measurements, and it is suspected that automated MCV and MCHC 
measurements of these samples are also inaccurate.37   
Problem 3: Species settings use cell volume to differentiate RBCs from platelets 
Another challenge in camelid hemogram interpretation arises from a lack of certainty that the 
automated RBC count provided by flow cytometry analyzers represents the true RBC 
concentration in a given sample.  The ADVIA 120/2120 systems use the same cytometer channel 
to analyze both RBCs and platelets (PLT).  Cells with volumes between 0-200 fL and hemoglobin 
concentrations between 0-50 g/dL are documented on the RBC volume/HC cytogram and 
respective volume and HC histograms.32  Since PLTs have volumes greater than 0 fL and lower 
refractive indices than RBCs, they are included in the bottom left corner of the RBC cytogram.  
The analyzer then divides the optical reading area for RBCs and PLTs at the 30 fL threshold – all 
cells with volumes greater than 30 fL are included in the RBC optical read area and counted as 
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RBCs, while cells with volumes between 0-30 fL are included in the PLT optical read area and PLT 
count, and mapped on a separate PLT cytogram.32  The ADVIA uses “integrated RBC/platelet 
analysis” to differentiate large PLTs (volumes between 20-60 fL) from other small particles of 
similar size, such as microcytic RBCs, RBC fragments, and RBC ghosts.  This analysis is performed 
on the basis of combined volume and refractive index measurements for individual cells.25,32 
 
Accurate RBC and PLT counts are therefore primarily dependent on accurate cell volume 
measurements, which in turn are dependent on the cells undergoing adequate sphering 
reactions.  While there is no evidence to suggest that camelid PLTs are not susceptible to 
sphering reactions in the RBC/PLT reagent, their RBCS appear to be resistant to this shape 
change, as described above.  It therefore seems possible for a small RBC to be incorrectly sized 
and counted as a platelet, or vice versa.  Additionally, since camelid RBCs are suspected to be 
smaller than those of other mammalian species, including humans, even an accurately sized RBC 
may fall into the PLT volume range if the appropriate species threshold is not used.28,39  In 
human patients with microcytic anemia, the potential for overestimation of platelet counts by 
optical analyzers has been recognized.40  One recent study identified the use of the reticulocyte 
channel as a method to improve the accuracy of optical platelet counts in these patients, since 
the platelets take up thiazole orange stain but the mature, microcytic RBCs do not.40   
 
The ADVIA’s veterinary software allows for the analysis of a blood sample according to multiple 
pre-defined species settings, which set different thresholds for the ideal volume and 
hemoglobin concentration measurements of RBCs.  For example, the pre-determined volume 
threshold for the goat setting is lower than that for the dog setting, since goats are known to 
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have lower MCVs than dogs.  Analyzing the same blood sample on multiple species settings will 
provide different absolute RBCs counts and RBC indices (MCV, MCHC, etc), as will manually 
altering the manufacturer’s pre-set thresholds for a given species setting.41  This suggests that if 
the true expected volume of camelid RBCs was known, the ADVIA could be used to provide 
accurate RBC counts.  However, as stated in the first problem, the true volume of camelid RBCs 
is still uncertain.             
 
Even though electrical impedance counters are less dependent on a specific cell shape than 
optical flow cytometers, they still use size thresholds to determine which particles to include in 
their counts, and to separate cell populations.23,42,43  Overestimation of PLT counts by electrical 
impedance methods has been described in human patients with microcytic anemia, specifically 
those with MCVs less than 70 fL.40  Knowledge of camelid RBC volume is therefore important for 
obtaining accurate RBC counts regardless of which automated instrument is utilized.     
Problem 4: Automated cell volume measurements and RBC counts are used to 
determine other RBC values 
Automated flow cytometry analyzers such as the ADVIA 120/2120 provide several RBC values 
which are the result of direct measurements of individual cells, including MCV and CHCM.  
Absolute RBC counts are also directly measured by the analyzer, as described above, although 
they are dependent on the initial cell volume measurement.  Other values, such as hemoglobin 
concentration (HGB) of the blood sample, are the result of direct chemical analysis that is not 
dependent on cell size, shape, or number.   
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In the ADVIA 120/2120, HGB is measured spectrophotometrically after lysis of the RBCs.25  The 
active ingredient in most RBC lysis buffers is ammonium chloride, which causes colloid osmotic 
lysis following diffusion of NH3 into the cells, subsequent anion exchange via band 3 proteins, 
and ultimately net influx of chloride anions.44  Studies utilizing various concentrations, volumes, 
and incubation times of ammonium chloride solutions have been performed with alpaca blood, 
however these studies do not describe an endpoint for measurement of complete hemolysis (or 
potentially a lack thereof).45,46  A separate study using camel blood described incomplete lysis of 
the RBCs after incubation with an ammonium chloride buffer solution.47  Additionally, protein 
electrophoresis of RBC membrane ghosts from humans and llamas shows residual hemoglobin 
in the llama membranes, suggesting incomplete lysis of the RBCs during ghost preparation.20  
However, additional research into the susceptibility of camelid RBCs to lysis with colloid osmotic 
buffers is lacking, and the specific composition of the ADVIA 120/2120 hemoglobin reagent is 
unknown.  The hemoglobin concentrations measured by the ADVIA in the present studies 
appear physiologically appropriate, and are similar to those described by other investigators.3,28  
Ultimately, however, the degree to which camelid RBCs undergo hemolysis in the ADVIA 
120/2120 hemoglobin reagent is uncertain, and warrants further investigation.    
 
Additional values relating to erythron evaluation are calculated, rather than directly measured, 
by the analyzer.  One of these calculated values is hematocrit (HCT), which is analogous to the 
sample’s packed cell volume (PCV), a value that is often obtained manually after centrifugation 
of whole blood.  The ADVIA calculates HCT as a product of the RBC count and the MCV.  
Therefore, if the measured RBC count and MCV of a sample are suspected to be inaccurate, then 
the analyzer’s HCT calculation will also be inherently inaccurate.  As mentioned briefly above, 
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most automated hematology analyzers including the ADVIA 120/2120 also provide a calculated 
mean RBC hemoglobin concentration (MCHC), which is often nearly identical to the measured 
CHCM in most species.25  The MCHC is derived from division of the hemoglobin (HGB) 
concentration of the sample by the calculated HCT.  While HGB may be unaffected by the other 
problems which plague automated camelid hematology analysis (see above), the MCHC value 
will be inaccurate in camelids due to its incorporation of the analyzer’s calculated HCT.  Previous 
studies have suggested measuring a manual PCV and substituting this value for HCT in the MCHC 
equation.3,28 
Problem 5: Mean concentration of RBCs in healthy camelids exceeds the reportable 
range of the ADVIA 
Automated camelid RBC counts from both flow cytometry and impedance analyzers are 
susceptible to error as a consequence of their dependence on accurate individual cell volume 
measurements, as described above.  These values are therefore suspected to be inaccurate, 
although the degree of error and difference from the true value (bias) for each method are 
uncertain.  Additionally, camelids are known to have a higher concentration of RBCs in their 
peripheral circulation (millions of cells/µL of blood) than many other species.  Estimates of 
absolute RBC counts in camelids range from 10-17 million cells/µL, with some reports of counts 
approaching 18 million cells/µL.3,4  This fact is problematic because the upper end of the 
reportable range for RBC counts on the ADVIA 120/2120 is 7 million cells/µL.31   
Reportable range (also known as analytic measurement range), as defined by the Clinical 
Laboratory Improvement Amendment (CLIA) and the College of American Pathologists (CAP), is 
the “range of analyte values that a method can directly measure on the specimen without any 
dilution, concentration, or other pretreatment not part of the usual assay process.”48  This range 
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is determined by assessing an instrument’s linearity, or the presence of a straight-line 
relationship between measured analyte value and the true specimen value (equivalent to a 
slope of 1 on an x vs. y scatterplot).  The upper end of the reportable range is typically defined 
as the highest analyte concentration at which this linear relationship is observed, or in other 
words the highest instrument value that can be trusted as accurate for a particular analyte.48  An 
important question when analyzing camelid blood is therefore whether the ADVIA will 
underestimate the RBC count when the true RBC concentration exceeds the instrument’s 
reportable range.  Additionally, because RBCs are present in such high concentrations in healthy 
camelids, it is possible that the cells would not flow single-file through the path of the laser 
beam, leading to a falsely decreased absolute count as multiple cells are counted as one.  For 
this reason, it has been suggested that impedance particle counters might provide more 
accurate RBC counts than optical flow cytometry analyzers, although it is important that the 
correct size thresholds and sample dilutions are used, as described above.3        
What is known currently 
In summary, there is abundant evidence to suggest that automated complete blood count 
analysis in camelid species is inaccurate.  However, validated methods to improve the accuracy 
of this analysis are lacking.  Current recommendations include manual measurement of a PCV 
instead of using the ADVIA’s HCT, and calculation of MCV and MCHC based on the PCV.28  
However, the MCV calculation includes the RBC count, so the accuracy of this calculated value is 
still dependent on obtaining an accurate absolute RBC concentration.  To date, there is no 
validated, standardized method for obtaining a trusted RBC count in camelids, either by 
automated (flow cytometer or impedance) or manual (hemacytometer) methods, and previous 
studies reporting hematologic reference intervals for these species have utilized different 
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methods.3,28,39  Several advanced techniques have been described in human hematology to aid 
in the characterization of RBC size and morphology in various disease states, however the 
practical applicability of these methods for analysis of large numbers of RBCs in clinical blood 
samples has yet to be determined.49,50 
Mycoplasma haemolamae 
Hemotropic mycoplasma (hemoplasma) infections have been described in numerous vertebrate 
species, with nearly global geographic distribution.  Many of these wall-less bacterial organisms 
belong to the genus Mycoplasma, which combines organisms previously classified as 
Hemobartonella or Eperythrozoon.51  Some hemotropic mycoplasmas, including M. 
haemolamae, have an additional qualifier of Candidatus, indicating that aspects of their biology 
are not fully described.52  Throughout the remainder of this thesis, this organism will be referred 
to as M. haemolamae.  Mycoplasma organisms have specific host ranges, but these organisms 
share similar morphologic characteristics in all host species, being observed epicellularly as small 
basophilic ring, coccoid, or rod-shaped structures on the surface of RBCs on Wright’s stained 
blood smears, which occasionally cause slight indentations of the cell membranes.  If there is a 
delay in blood smear preparation, the bacteria can fall off the RBCs ex vivo, leading to their 
appearance extracellularly in the background of the smear, and potentially increasing the 
likelihood that they may be mistaken for artifact.52  In recent years, sequencing of the M. 
haemolamae genome has allowed for development of a polymerase chain reaction (PCR) assay 
for more definitive diagnosis of infection in camelid blood samples.53,54 
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Clinical disease caused by the hemotropic mycoplasmas often involves anemia.  Clinical anemia 
due to extravascular hemolysis is observed with hemoplasma infections in cats and pigs.52,55 In 
other species (dogs, ruminants, camelids), splenectomy or immunologic compromise is often 
necessary to observe clinical disease in bacteremic animals.51,52  Hypoglycemia has also been 
noted in cases of clinical Mycoplasma infections, although the pathophysiology of this finding is 
uncertain.52  In camelids, clinical anemia (defined as decreased PCV in most reports) has been 
described in cases of M. haemolamae infections, although clinically affected animals are usually 
young, stressed, or debilitated by a concurrent illness (such as gastrointestinal parasitism or 
malnutrition), or otherwise immunosuppressed.  Clinical disease in otherwise healthy, adult 
animals infected with M. haemolamae appears to be uncommon.3,52,56,57 
 
In most species, transmission of these organisms is presumed to occur via arthropod vectors 
(fleas, ticks, etc), however supporting evidence for this presumption is lacking.52  Vertical 
transmission of M. haemolamae is also suggested in camelids based on reports of bacteremia 
with or without clinical disease in 1- and 4-day old crias.58,59  In the 1-day old llama, neither the 
cria nor the dam were anemic, however large numbers of Mycoplasma organisms were 
observed on the cria’s blood smear.  Organisms were not observed on a blood smear from the 
mother, although PCR assays were not available at the time of this report to definitively exclude 
the possibility of maternal bacteremia.58  In contrast, the 4-day old alpaca was anemic with large 
numbers of organisms observed on a blood smear.  The dam in this case was not anemic and did 
not have organisms on a blood smear, but both the dam and cria had PCR evidence of M. 
haemolamae infection.59   
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The development and increasing availability of the M. haemolamae PCR assay has allowed for 
assessment of the prevalence of this infection in camelid populations, which appears to vary 
substantially based on geographic location and likely other husbandry-related factors.  In a 2010 
study of alpacas and llamas in Chile and Peru, the prevalence of infection ranged from 9-19%.56  
A slightly higher prevalence was identified in an alpaca population in England (29%),60 while a 
much lower prevalence was described in a group of 206 alpacas in New Zealand (0.97%).61   
 
Despite their utility in diagnosing the presence of the bacteria, interpretation of M. haemolamae 
PCR results can be difficult.  As noted above, clinical illness secondary to this infection is 
uncommon in otherwise healthy adult camelids, so the significance of a positive PCR assay is 
uncertain.  If the animal is healthy, is it at increased risk of developing anemia?  If the animal is 
anemic, is the anemia a direct consequence of M. haemolamae infection, or is there evidence of 
a concurrent disease process (i.e. gastrointestinal parasitism or systemic inflammation) that may 
be contributing to the decreased RBC mass?   Additionally, there is experimental evidence which 
indicates that infected alpacas may remain PCR positive for M. haemolamae after treatment 
with oxytetracycline, despite the clearance of visible organisms from blood smears and 
resolution of clinical anemia.62  Additional research is needed to further investigate the 
relationship between M. haemolamae PCR status and RBC values in cases of apparent 
subclinical infection.  
Camelid parasitology 
Gastrointestinal (GI) nematode infestations represent another common source of potential 
clinical illness in camelid species living in the southeastern United States.  Commonly identified 
nematodes include: Haemonchus contortus, Trichostrongylus axei, Teladorsagia circumcincta, 
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Ostertagia ostertagi, Lamanema chavezi, Nematodirus batti, Aonchotheca (Capillaria) spp., 
Trichuris spp., and Oesophagostomum spp.63  Of these parasites, only Lamanema chavezi is 
specific to llamas and alpacas; the remainder are also found in small and/or large ruminant 
species.63,64   
 
The clinical significance of many of these nematodes in camelids is uncertain, with the exception 
of H. contortus, which is a strongylid nematode known to cause severe hemorrhagic anemia.  
The pathogenesis of H. contortus infections has been well-defined in sheep,65 and recently in 
llamas and alpacas.66  H. contortus resides in the abomasum of sheep and goats, and in the third 
gastric compartment (C3) of camelids.  Whole blood is lost as the worms feed on the mucosal 
blood supply, as well as secondary to mucosal irritation.  Clinical signs of anemia often include 
mucous membrane pallor, weight loss, and submandibular edema.66   
 
In contrast to M. haemolamae infections, in which the relationship between PCR status and 
susceptibility to clinical disease is uncertain, the link between H. contortus infections and clinical 
anemia is well known.  Several methods exist for diagnosis and differentiation of GI nematode 
infections, including identification of adult worms within the GI tract at necropsy, various fecal 
flotation and egg counting methods, fecal culture, PCR, and lectin staining.63,66,67  Fecal flotation 
and calculation of a fecal egg count (FEC) is one of the most common ante-mortem diagnostic 
methods for GI nematodes, and is also commonly used as a screening test at the herd level to 
determine the proportion of animals likely to be shedding large numbers of eggs onto the 
pasture.  Screening of animals within a herd based on body condition scoring and FAMACHA 
scores (see below) is currently recommended in order to allow for targeted deworming of 
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animals likely to have high egg counts, since unnecessary deworming of the entire herd is likely 
to decrease refugia and promote resistance of the parasites to commonly used medications, 
limiting the efficacy of these treatments when animals become clinically ill.68 
 
The modified McMaster technique for obtaining FECs is most often described, in which a fecal 
sample is mixed with a flotation solution and then loaded into a counting chamber.  Microscopic 
evaluation of the chamber allows for the visual identification of egg types (strongylid vs. other 
nematode vs. coccidia, etc).  Variations of this technique have been reported, although the use 
of a sucrose flotation solution with a specific gravity of 1.200-1.350, and a chamber volume of 
1.0 mL seem to yield the highest stronglyid egg counts in both sheep and camelids.67,69  In 
addition to identifying the presence of a parasite infestation, an FEC also provides a semi-
quantitative assessment of the animal’s nematode burden, since a larger number of adult 
female worms in the gastric compartment would be expected to produce a proportionally larger 
number of eggs.65,70  Although strongylid eggs of all species appear similar on flotation, 
necessitating the use of additional techniques (larval culture, lectin staining, etc) to differentiate 
them, H. contortus is the nematode which is most commonly present, and of most clinical 
concern.66   Additionally, both FEC and adult worm numbers have been shown to exhibit a linear 
relationship with the amount of blood loss in sheep experimentally infected with H. contortus.70   
 
The FAMACHA system (named for its inventor, Dr. Francois “Faffa” Malan) is another method 
commonly associated with diagnosis of GI nematode infections in small ruminants and camelids.  
The conjunctival mucous membrane color of an animal is compared to a standardized card with 
five shades of pink (ranging from white to bright pink-red).  This is used to provide an estimate 
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of the severity of the animal’s anemia and its relative need for deworming medication, given 
that H. contortus infection is the most likely cause of clinical anemia.  Pale white mucous 
membranes correspond to a score of 5, which is the most severe degree of anemia.  Bright pink 
mucous membrane color would receive a score of 1 (clinically normal).  In one study in sheep 
and goats, a FAMACHA score of 3 correlated to an FEC of approximately 1000 eggs per gram 
(epg), although there appears to be substantial geographic variation in typical FEC ranges.71  This 
system has high specificity and fair sensitivity for detection of anemia in sheep and goats, 71 and 
in alpacas and llamas, 72 and there is good correlation between FAMACHA scores and HGB and 
HCT measurements of peripheral blood.73 
 
Positive correlation has also been demonstrated between FEC and PCV in clinically ill alpacas 
and llamas, 66 and in experimental and natural H. contortus infections in sheep.73,74  To date, no 
research has been done to determine whether there is a correlation between FEC and RBC 
values in clinically healthy camelids, and there is also a lack of certainty in the interpretation of a 
clinically significant FEC value in otherwise healthy animals.  In one study performed in the 
southeastern United States, the majority of anemic camelids had an FEC of ≥1000 epg, 72 while 
in another study performed in New Zealand a fecal egg count of 250 epg was reported as “high 
and clinically significant.”61          
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Abstract  
  
Background: Accurate measurement of erythrocyte values by automated hematology analyzers 
requires isovolumetric sphering of the cells.  Camelid erythrocytes have unique membrane 
characteristics, which make them resistant to sphering.  Validation of an optimized method for 
hematologic analysis of camelid blood has not been published.     
Objectives: Demonstrate whether camelid erythrocytes sphere in the ADVIA RBC/PLT reagent (a 
sphering reagent), and determine the optimal ADVIA setting for camelid CBC analysis. 
Methods: Camelid and canine blood were each added to ADVIA RBC/PLT reagent or saline at a 
1:625 dilution, and evaluated by light microscopy for erythrocyte sphering.  Camelid blood (n = 
25) was analyzed on a Z2 Coulter counter using one or more lower volume thresholds (4, 5, 6, 8, 
10, 12 fL) to determine the optimal threshold for manual RBC quantification.  Additional camelid 
blood (n = 132) was analyzed on an ADVIA 120 hematology analyzer using one of three settings 
(bovine, equine, camelid).  The analyzer’s playback feature was used to obtain data using the 
other two settings.  The playback feature was also used to obtain data using the goat setting on 
a subset of samples.  A manual packed cell volume (PCV) was measured, and manual 
calculations performed for mean cell volume (MCV) and mean cell hemoglobin concentration 
(MCHC).  RBC values (RBC count, MCV, MCHC, and HCT) were compared between all ADVIA 
settings, and between each setting and manual calculations using Passing-Bablok regression and 
Bland-Altman plots.   
Results: Canine erythrocytes sphere when mixed with ADVIA RBC/PLT reagent, while camelid 
erythrocytes do not.  The ADVIA 120 equine and camelid settings are identical and provide the 
closest approximations to manual estimates of erythrocyte and platelet counts.  MCV, MCHC, 
and HCT from all settings are significantly different from manual calculations.  The 8 fL threshold 
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of the Z2 Coulter counter yields the highest RBC count, although some platelets may be included 
in the count.     
Conclusions: Camelid erythrocytes do not sphere, resulting in inaccurate erythrocyte values 
from automated hematology analyzers.  Optimal determination of CBC data requires a 
combination of automated and manual methodologies.   
 
Background 
 
Results from an automated veterinary hematology analyzer are highly dependent on the species 
setting that is used to analyze the blood sample, as these settings must be optimized to account 
for differences between species.  This is especially true for values related to erythrocytes and 
platelets.  It has historically been difficult to obtain accurate hematology results for camelid 
species, since their red blood cells (RBC) and platelets are characterized by unique features that 
are not present in more commonly studied domestic animals, including elliptically-shaped RBCs 
and extremely small platelets.  These characteristics can affect the way that the cells are 
identified and measured by automated analyzers, making optimization of a camelid setting on 
any hematology analyzer a challenge.  To date, there are no published validation studies 
identifying optimal settings for camelids, although anecdotal reports indicate that the equine 
setting of the ADVIA 2120 is preferred.28,39  
Camelid erythrocyte structure and function 
Camelid red blood cells are small, flat, and elliptical, with a rigid cell membrane.  It is thought 
that these characteristics aid in adaptation to living at high elevations and in arid environments, 
by providing increased oxygen delivery and resistance to osmotic lysis, respectively.2  Specific 
differences in the camelid erythrocyte plasma membrane, including relative increases in the 
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proportions of certain proteins, result in decreased erythrocyte deformability and a consequent 
lack of shape change when exposed to a variety of substances that alter membrane lipids in 
vitro in other species.5  While this resistance to deformation likely increases the physiologic 
resistance to erythrocyte lysis during periods of dehydration, it also presents challenges to our 
ability to accurately identify and quantify camelid RBCs using conventional automated 
hematology methods. 
Hematology analyzer methodology 
Automated optical flow cytometry analyzers such as the ADVIA 120/2120 (Siemens Healthcare 
Diagnostics, Tarrytown, NY) identify and quantify RBCs and platelets based on species-specific 
volume and hemoglobin concentration thresholds.  However, the accurate determination of 
these parameters requires the cells to be isovolumetrically sphered (i.e. turned into spheres 
without changing their cell volume).  This is accomplished in samples from species with 
biconcave disc-shaped RBCs by the addition of a solution of sodium dodecyl sulfate (SDS) and 
subsequent fixation with glutaraldehyde.25  SDS and glutaraldehyde are the main components of 
the ADVIA RBC/PLT reagent.32  Since cell shape is eliminated as a variable in spherical cells, their 
light scatter properties can be assessed based on the Mie theory of light scatter by spheres, and 
converted to measurements of volume as well as internal complexity (refractive index – 
translated by the analyzer into hemoglobin concentration).25  Since cell volume measurements 
from optical analyzers are used to identify a cell as an RBC (vs. a platelet) and to determine the 
absolute RBC count and mean cell volume (MCV), the accuracy of these values is highly 
dependent on this sphering reaction.  Additionally, other RBC values including mean cell 
hemoglobin concentration (MCHC) and hematocrit (HCT) are based on RBC and MCV 
measurements, and are therefore affected by any inaccuracies in these measurements.  Camelid 
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RBCs are also smaller than those of most other domestic species.  The estimated MCV of alpaca 
RBCs was 21-28 fL in one study,28 while the typical canine MCV is often greater than 60 fL.  As a 
result, there is increased risk of RBCs being counted as platelets by the ADVIA if their volume 
measurement is inaccurate or the incorrect species thresholds are used.  Based on knowledge of 
camelid erythrocyte morphology and membrane structure, as well as on prior studies,5 it is 
reasonable to hypothesize that camelid RBCs will be resistant to sphering with the ADVIA’s 
RBC/PLT reagent, and that RBC quantification and associated indices obtained from the ADVIA 
120 will differ significantly from their true values as determined by other manual and automated 
methods.  
 
As there is currently no validated camelid setting for the ADVIA 120/2120, nor a way to predict 
the degree or direction of any inaccuracies introduced by a lack of RBC sphering, the goal of this 
study was to determine which ADVIA species setting (bovine, equine, or goat) would provide the 
most accurate CBC values related to RBCs and platelets, as well as to determine the bias 
between ADVIA RBC indices and those obtained with manual methods.  It was hypothesized that 
absolute RBC and PLT counts will vary significantly between different species channels on the 
ADVIA, and that the optimal method for determining accurate CBC data will require a 
combination of automated and manual methods.  Results of this study are intended to aid in the 
development of more accurate camelid hematology reference intervals, and potentially in the 
design of future studies of certain related hematologic disorders, such as canine hereditary 
elliptocytosis. 
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Materials and Methods 
RBC sphering 
Given that the ADVIA’s measurement of MCV and quantification of RBCs is dependent on proper 
RBC sphering, if camelid erythrocytes are resistant to sphering then CBC results from the ADVIA 
will be inaccurate regardless of which species setting is used.  One EDTA 
(ethylenediaminetetraacetic acid)-anticoagulated sample each of canine and camelid whole 
blood were used to prepare serial dilutions in both the ADVIA RBC/PLT reagent and normal 
saline (as a control).  The specific composition of the RBC/PLT reagent is proprietary 
information; however, its key ingredients are sodium dodecyl sulfate and a glutaraldehyde 
fixative.25  Canine and camelid blood samples from obtained from hospital patients who were 
not anemic based on laboratory reference intervals, where blood had been collected as part of 
their clinical evaluation.  A final dilution of 1:625 (blood to reagent or blood to saline) was used 
[David Zelmanovic, personal communication].  The total volumes of the dilutions were 
multiplied by a factor of 3 via trial and error to increase the final volume of the dilution while 
maintaining the desired final concentration of 1:625, since the sphering of normal human RBCs 
is dependent on the presence of a volume of reagent sufficient to completely coat the surface of 
each cell.75  For example: 
 1st dilution: 10 µL blood to 240 µL reagent/saline = 1:25 
 2nd dilution: 10 µL 1st dilution to 240 µL reagent/saline = 1:625 
 Multiply volume by a factor of 3: 
 1st dilution: 30 µL blood to 720 µL reagent/saline = 1:25 
 2nd dilution: 30 µL 1st dilution to 720 µL reagent/saline = 1:625 
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A drop of each final dilution was placed on a slide with a coverslip, and immediately examined 
with light microscopy at 500x magnification to evaluate for RBC sphering.  
RBC linearity of the ADVIA 
The range of absolute RBC counts measured by the ADVIA is 0-7,000,000 cells/µL, according to 
the ADVIA 120 performance specifications.31  However, camelid blood has an erythrocyte 
concentration that is 2-3 times that of humans and other domestic mammals, and healthy 
llamas are reported to have RBC counts up to 18,000,000/µL, far exceeding the technical 
specifications of the ADVIA.3,29  In order to evaluate the ADVIA’s ability to provide accurate RBC 
counts above the manufacturer’s specified range, the linearity of the ADVIA 120 was assessed 
through serial dilution of equine blood.  Equine blood was used because the equine setting of 
the ADVIA has been validated for horses, and because horses have relatively low MCVs among 
the common domestic species (<60 fL), allowing for artificial concentration of a blood sample to 
an absolute RBC count within the anticipated reference interval of camelid species without 
exceeding a supraphysiologic PCV.4,27   
 
An EDTA-anticoagulated equine whole blood sample with an ADVIA 120 RBC count of 
6,220,000/µL was concentrated via centrifugation at 3500 rpm for 3 minutes.  The packed RBCs 
in the centrifuged sample were re-suspended in a small volume of autologous plasma, and 
analyzed in duplicate using the ADVIA 120.  This concentrated sample was then serially diluted 
into four additional pools using increasing volumes of autologous plasma – 4:1, 3:2, 2:3, and 1:4 
(packed RBCs to plasma).  These four pools were measured in triplicate on the ADVIA 120, as 
was a sample of autologous plasma.  Measured RBC counts for each dilution level were 
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averaged, and linear regression analysis was used to assess the correlation of the measured and 
expected values for each dilution.  
Determination of appropriate RBC size thresholds – part I 
In order to determine which cell volume threshold would be most likely to provide accurate RBC 
and platelet counts, camelid whole blood was analyzed using a Z2 Coulter particle counter 
(Beckman Coulter Inc., Fullerton, CA).  Compared to the ADVIA, which identifies and counts cells 
based on their light scatter properties (volume and refractive index), the Z2 counts cells as 
particles that cause a measurable change in electric resistance as they flow across an aperture 
within the analyzer.42  Unlike the ADVIA and similar optical flow cytometry methodologies, 
which require RBCs to be isovolumetrically sphered in order to be correctly sized and counted, 
cell shape does not affect Z2 particle counts.  Instead, lower and upper volume thresholds are 
set by the operator, and all cells (particles) whose volumes fall between these thresholds are 
counted.  This “aperture-impedance principle” of cell counting has been identified as a 
reference method for red and white blood cell counting and sizing in human hematology,43 as it 
is both more precise and accurate than manual methods such as hemacytometer chamber 
counting.   
 
Venous whole blood was collected from a group of camelids (adult llamas and alpacas) in New 
York State between November 2009 and October 2015.  This group included both clinically 
healthy animals, as well as those presenting for various disease conditions.  Blood was collected 
into K2EDTA tubes, and transported to the clinical pathology laboratory at Cornell University 
College of Veterinary Medicine.  Blood from healthy animals was collected with informed owner 
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consent according to approved IACUC protocols.  Blood from ill animals was collected as part of 
their clinical evaluation. 
 
Samples were analyzed on the Z2 counter at various lower volume thresholds: 4 fL, 5 fL, 6 fL, 8 
fL, 10 fL, and 12 fL.  According to the International Council for Standardization in Hematology, 
the ideal lower threshold for RBC counts should be set between the volumes of platelets and 
red blood cells,43 so as to exclude as many platelets and include as many RBCs as possible in the 
count.  Since the exact volume of camelid RBCs is unknown and the degree of overlap with 
platelet volume (if any) is uncertain, all samples were run using at least two of the size 
thresholds listed above, in an attempt to identify the ideal RBC size threshold.  All samples were 
analyzed at the 8, 10, and 12 fL thresholds, and after preliminary analysis the data for the lower 
thresholds (4, 5, and 6 fL) were excluded based on the apparent inclusion of two distinct cell 
populations (RBCs and platelets) on the Z2 histograms.   
 
Briefly, blood samples were prepared for analysis by creating two serial dilutions in an isotonic 
electrolyte solution (Z Pak, Beckman Coulter Inc., Fullerton, CA).  The first dilution was prepared 
by pipetting 20 mL of solution into a cuvette (Accuvette, Beckman Coulter Inc., Fullerton, CA), 
removing 40 µL of the solution and then adding 40 µL of well-mixed whole blood (1:500 
dilution).  20 mL of electrolyte solution was added to a second cuvette, from which 200 µL was 
removed and replaced with 200 µL of sample from the 1:500 dilution (final dilution: 1:50,000).   
The 1:50,000 dilutions were used to perform RBC counts in duplicate at each lower volume 
threshold.  An upper volume threshold of 120 fL, an aperture diameter of 100 µm, and a 
resolution of 256 nm were held constant for all Z2 counter analyses.        
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A CBC analysis was also performed on each sample using the ADVIA 2120 equine setting (20-70 
fL RBC volume threshold), and the ADVIA’s playback feature was used to obtain results on the 
bovine (5-65 fL) and goat (0-50 fL) settings.   
A manual PCV was also measured on each sample, using a microhematocrit centrifuge for 10 
minutes at 13,200 g.   
Determination of appropriate RBC size thresholds – part II 
As described above, the cell counts obtained from the Z2 Coulter counter are a reflection of the 
number of particles in a sample within a specified volume range, without providing any 
additional information regarding the identity of the particles.  In species with known RBC 
volume, one can be reasonably confident that a whole blood sample analyzed with the 
appropriate size thresholds will yield an accurate RBC count.  However, given that normal RBC 
volume is unknown in camelid species, it is also unknown how closely Z2 RBC counts reflect the 
true RBC count in a given animal.  For example, if the lower volume threshold is too high, a 
proportion of smaller RBCs may be excluded from the total count.  Additionally, if the lower 
threshold is too low, platelets may be included, falsely increasing the RBC count.  In order to 
further validate the Z2 Coulter counter as a reference method for camelid RBC counts and size 
determination, additional blood samples were obtained from four clinically healthy, non-anemic 
llamas (PCV ≥ 22%, the lower limit of the camelid reference interval at Cornell CVM) and 
separated into RBCs and platelet-rich plasma (PRP).  Whole blood, RBCs and PRP from each 
animal were analyzed on both the Z2 counter (at various lower thresholds) and the ADVIA 2120 
(various species settings).  The Z2 lower volume threshold yielding the highest count on the RBC 
sample and the lowest count on the PRP sample would be expected to represent the most 
accurate volume threshold for camelid RBCs.   
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Whole blood 
Each whole blood sample (9 cc) was collected into a 20 cc plastic syringe containing 1 cc of acid 
citrate dextrose (ACD) as an anticoagulant, as this is the recommended anticoagulant for use in 
preparation of platelet-rich plasma.76  The sample was well-mixed by gentle inversion, and 
transferred into a 15 cc polypropylene conical tube.  CBC analysis was performed on each whole 
blood sample using the ADVIA 2120.  Each of the four samples was initially run on one of three 
species settings: bovine, goat, and equine, and the instrument’s playback feature was used to 
obtain results for the other two settings.  The initial setting was determined randomly for each 
sample.  A blood smear was prepared from each sample, and a manual PCV was measured, as 
described above.  Based on preliminary results from part I of this portion of the study, each 
whole blood sample was also analyzed on the Z2 Coulter counter at three lower volume 
thresholds: 8 fL, 10 fL, and 12 fL.  The upper volume threshold, resolution, and dilutions were 
held constant across all lower threshold settings, as described above.  Each sample was 
measured 2-4 times each, depending on available sample volume, and the mean of the 
measurements was calculated. 
 
Platelet-rich plasma 
Platelet-rich plasma (PRP) was prepared according to a previously described protocol.76 The 
conical tube containing the remaining whole blood was centrifuged at 720 x g for 15 minutes at 
21oC.  The plasma was removed, leaving the buffy coat and RBCs at the bottom of the tube.  The 
plasma (PRP) was analyzed on the ADVIA 2120 using the same species setting as for the 
patient’s whole blood sample, and a modified Wright’s stained direct smear was prepared to 
verify the presence of platelets and relative absence of RBCs and WBCs.  The PRP was also 
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analyzed on the Z2 counter as described above, at each of the three lower volume thresholds (8, 
10, and 12 fL).  
 
The remaining PRP sample from each animal was centrifuged a second time at 720 x g for 15 
minutes.  The supernatant was removed and centrifuged in an Eppendorf tube at 13,000 rpm for 
5 minutes.  The supernatant from this hard spin (platelet-poor plasma, PPP) was analyzed on the 
ADVIA 2120 and at each of the lower volume thresholds on the Z2 counter.   
 
Platelet-poor RBC suspension   
The buffy coat and a small portion of the top of the RBC layer was removed from the remaining 
RBCs in the conical tube, and discarded.  In an Eppendorf tube, 650 µL of PPP and 260 µL of 
concentrated RBCs were combined and gently mixed, in order to obtain a platelet-poor RBC 
sample with a similar PCV to that of the original whole blood sample.  A manual PCV was 
performed.  A blood smear was prepared from this reconstituted RBC sample, and stained with 
modified Wright’s stain to microscopically verify the presence of RBCs and relative absence of 
platelets and WBCs.  The sample was also analyzed once on the ADVIA 2120 using the sample’s 
original species setting, and on the Z2 counter at the 8, 10, and 12 fL lower volume thresholds.  
Additionally, a portion of the reconstituted RBC sample was mixed with an equal volume of both 
PRP and PPP (i.e. 200 µL of RBCs plus 200 µL of PRP or PPP).  Each of these samples was also 
analyzed on the ADVIA 2120 and the Z2 counter, and a manual PCV was performed as described 
above.  The sample types and analyses performed on each sample are summarized in Figure 1.  
All tables and figures are located in the Appendix. 
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Patient selection and sample collection 
Venous whole blood was collected from clinically healthy adult (≥ 1-year-old) alpacas and llamas 
from 12 farms in eastern Tennessee between July and October 2015.  Health was defined as a 
lack of significant abnormalities on physical examination as determined by an experienced 
veterinarian, a FAMACHA score of 3/5 or lower,72 a body condition score (BCS) of 2.5/5 or 
higher, and no history of illness or injury within the previous 3 months.  All examinations and 
sample collections took place on the farms, and informed client consent was obtained for all 
procedures (approved UT IACUC protocol 2298-0914). 
 
A maximum of 12 animals were collected per farm.  Individual and herd histories were obtained, 
including species, age, sex, pregnancy/breeding status, housing, diet, vaccines, and parasite 
control practices.  After examination of each animal, a maximum of 10 mL of blood was 
collected by an experienced veterinarian from an external jugular vein using a 12 mL plastic 
syringe (Covidien LLC, Mansfield, MA) attached to a 20 gauge, 1.5-inch needle (Covidien LLC, 
Mansfield, MA).  The blood was placed in a 4 mL K2EDTA tube (Becton Dickinson, Franklin Lakes, 
NJ) and transported to the University of Tennessee clinical pathology laboratory in a cooler that 
was maintained at 4oC until arrival.  Samples were promptly analyzed by trained laboratory 
personnel, with all analyses completed within 6 hours of sample collection.  Samples were 
evaluated for appropriate filling of the EDTA tube, and for clot formation and/or gross lipemia.  
Underfilled, clotted, and lipemic samples were excluded.  A CBC with reticulocyte count was 
performed on each sample using the ADVIA 120 hematology instrument according to laboratory 
standard operating procedures (SOP).  One of three species settings was used:  
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Bovine: RBC volume threshold of 5-65 fL 
 Equine: RBC volume threshold of 20-70 fL 
 Modified equine (referred to hereafter as Camelid): RBC volume threshold of 5-70 fL 
The true MCV of camelid RBCs in health is not known, although previous studies suggest a range 
of 21-28 fL based on manual calculations.28  Although the camelid setting is not a manufacturer-
defined species setting on the ADVIA, it was created in the UT clinical pathology laboratory 
because the lower end of the size threshold in the equine setting is very close to the expected 
size of camelid RBCs.  The lower size threshold of the camelid setting is hypothesized to allow 
better enumeration of smaller camelid RBCs.  This may become important if analyzing samples 
from camelids with conditions known to cause microcytosis, e.g. iron deficiency, since these 
small RBCs might be excluded from analysis on the equine setting.  Although the size thresholds 
for the camelid and bovine settings overlap substantially, pilot data for this study revealed 
significant differences in the RBC values between these two settings (data not shown).  This 
suggests that RBC evaluation by the ADVIA is dependent on factors other than RBC volume 
alone (i.e. hemoglobin concentration thresholds). 
 
The patient samples were randomly and equally distributed among the three settings to 
eliminate potential bias, and the playback feature of the ADVIA was used to adjust each animal’s 
results for the other two settings.  For example, if a sample was run on the equine setting, 
playback was used to obtain CBC results for the bovine and camelid settings, so that each 
physical sample was only measured once.  After all samples had been collected and analyzed, a 
subset of the samples was also randomly selected (using a random number generator) to be 
analyzed on the ADVIA’s goat setting (RBC volume threshold of 0-50 fL) using the playback 
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feature. Manual PCVs were determined following one minute of centrifugation in a rapid fixed 
angle head microhematocrit centrifuge (HemataStat II, EKF Diagnostics, Boerne, TX).  The 
centrifuge’s “read” function was used to determine the PCV; this function is calibrated for the 
microhematocrit’s centrifuge speed to provide a PCV that is comparable to a traditional 
microhematocrit centrifuge, but with results obtained more rapidly.  Proper microhematocrit 
centrifuge function was verified using an electronic tachometer prior to beginning the study, 
and a series of test centrifugations of camelid blood (data not shown) confirmed there is no 
significant difference in PCV with centrifugation times longer than one minute.  ADVIA 120 and 
manual PCV analyses were performed by a licensed medical technologist trained in instrument 
use and following laboratory SOPs.  The ADVIA 120 underwent daily quality control using 3-level 
QCM (OPTIpoint, Siemens Healthcare Diagnostics, Tarrytown, NY).   
 
A minimum of one blood smear was prepared from each sample, and reviewed by a medical 
technologist according to laboratory SOP.  Blood smear review included a leukocyte differential, 
RBC morphology review, and a manual platelet estimate.  Blood smears were also reviewed by a 
board-certified veterinary clinical pathologist.   
 
Additionally, venous whole blood samples were collected from camelid patients (alpacas and 
llamas) presenting to the University of Tennessee Veterinary Medical Center’s large animal 
hospital with various clinical complaints between January and May 2016, if a CBC was part of the 
attending clinician’s diagnostic plan.  For these animals, blood samples were collected, 
transported to, and processed by laboratory personnel according to the large animal clinic and 
clinical pathology laboratory SOPs.  The CBC (and reticulocyte count, if requested by the 
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clinician) was run using the ADVIA 120 camelid setting, and a manual PCV and blood smear 
review were performed.  CBC results were also obtained on the bovine and goat settings using 
the ADVIA’s playback feature. 
Statistical analyses 
Statistical analysis was performed using commercial software (MedCalc Statistical Software 
version 17.4 (MedCalc Software bvba, Ostend, Belgium; http://www.medcalc.org; 2017).  The 
distribution of RBC and PLT variables from all analyses was assessed for normality using the 
D’Agostino-Pearson test.  Repeated measures ANOVA with pairwise comparisons were 
performed to compare the RBC counts obtained from the three Z2 lower volume thresholds and 
from each of the ADVIA 2120 species settings (equine, bovine, and goat).  Repeated measures 
ANOVA with pairwise comparisons were also performed between the 8, 10, and 12 fL threshold 
Z2 particle counts for platelet-poor RBC, PRP, and whole blood RBC counts to determine 
whether the counts obtained at each threshold differed significantly from one another.  The 
lower Z2 threshold yielding the highest RBC counts while appearing to include the fewest 
platelets was used as the reference method for all future comparisons to the ADVIA and manual 
methods.     
 
A manual mean cell hemoglobin concentration (MCHC) was calculated using the ADVIA’s 
hemoglobin (HGB) measurement and the manual PCV for each EDTA whole blood sample.  
Calculated MCV values were also determined, using the manual PCV and RBC counts obtained 
from the Z2 counter.  Mean and median differences between the ADVIA and manual methods 
(Z2 RBC count, calculated MCHC, and calculated MCV) were determined, as well as the range of 
differences, and the proportion of ADVIA values within the allowable total error (TEa) range of 
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the manual methods.  The TEa ranges for the RBC values were based on the American Society for 
Veterinary Clinical Pathology’s (ASVCP) guidelines for hematology measurands.77  Passing-Bablok 
regression and Bland-Altman difference analysis were performed to assess for the presence of 
bias between the ADVIA’s hematocrit value (HCT) and manual PCV, the ADVIA’s RBC count for 
each species setting and the reference Z2 count, the ADVIA’s MCHC for each species setting and 
the calculated MCHC, and the ADVIA’s MCV for each species setting and the calculated MCV.  
Additionally, bias was calculated between the MCV calculated from the ADVIA’s equine RBC 
count and the MCV calculated from the reference Z2 count.  The ADVIA’s platelet count for each 
species setting was compared to manual platelet estimates from blood smear review using the 
Wilcoxon test for paired samples.  
Results 
RBC sphering 
Canine RBCs exhibit sphere formation when incubated with ADVIA RBC/PLT reagent, and retain 
a biconcave disc shape when incubated with normal saline, as examined by light microscopy.  In 
contrast, alpaca RBCs maintain a flat ellipsoid shape in both RBC/PLT reagent and normal saline 
(Figure 2), and do not exhibit sphere formation. 
RBC linearity of the ADVIA 
The mean measured RBC count of the equine autologous plasma sample was 330,000/µL 
(minimum), and the mean measured RBC count of the concentrated packed RBC sample was 
14,115,000/µL (maximum).  The maximum measured RBC count was within the laboratory 
reference interval for camelids at the University of Tennessee (7,900,000-17,000,000/µL).  The 
serial plasma to packed RBC dilutions yielded measured RBC counts between these minimum 
and maximum values (Table 1).  Measured RBC counts were compared to expected RBC counts 
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(based on the sample dilution), and the coefficient of determination (R2) for the correlation of 
measured RBC counts vs. expected RBC counts was 0.998 (p<0.0001) (Figure 3).   
Determination of appropriate RBC size thresholds 
EDTA-anticoagulated whole blood was collected from 25 camelids, four of which were anemic 
based on a laboratory PCV reference interval of 22-45% (Cornell University).  All samples were 
analyzed on the 8, 10, and 12 fL thresholds of the Coulter Z2 counter and on the equine, bovine, 
and goat channels of the ADVIA 2120.  The highest mean RBC counts were obtained with the 8 
fL lower threshold of the Z2 counter, compared to the 10 and 12 fL thresholds.  The mean RBC 
counts were significantly different (p<0.0001) between the three lower Z2 thresholds, however 
there was overlap between the 95% confidence intervals for all means (Figure 4).  The highest 
mean RBC count on the ADVIA was obtained on the equine channel, and the lowest mean RBC 
count was obtained on the bovine channel.  All ADVIA RBC counts were significantly different 
from all lower Z2 threshold RBC counts, with the exception of the ADVIA equine RBC count and 
the 12 fL Z2 count (p=0.785).  However, there was overlap between the 95% confidence 
intervals for all mean RBC counts (ADVIA and Z2) (Figure 4).      
 
ACD-anticoagulated whole blood was collected from four llamas, and analyzed as summarized in 
Figure 1.  The ADVIA, Z2, and PCV results for the original whole blood, PRP, PPP, and platelet-
poor RBC samples are listed in Table 2.  When the four platelet-poor RBC samples were analyzed 
on the 8, 10, and 12 fL lower thresholds of the Z2 counter, the highest mean RBC count was 
obtained with the 8 fL threshold, however there were no significant differences between the 
three lower Z2 thresholds (p>0.05) (Figure 5). 
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When the PRP samples were analyzed on the 8, 10, and 12 fL lower thresholds of the Z2 
counter, the lowest mean platelet count was obtained on the 12 fL threshold, and the highest 
mean platelet count on the 8 fL threshold.  Particle counts were significantly different between 
the lower Z2 thresholds (p = 0.015), however all PRP Z2 counts were significantly lower than the 
ADVIA platelet counts (all species settings) (p<0.0001) (Figure 6).  
 
The 8 fL lower threshold of the Z2 counter yielded the highest RBC particle counts on the 
platelet-poor RBC suspensions, however it is suspected that platelets may be included in these 
counts based on the results from the PRP experiments.  The 10 fL lower Z2 threshold yielded 
slightly lower counts for the platelet-poor RBC suspensions, but also provided slightly lower 
counts for the PRP samples, increasing confidence in the RBC count estimates.  The 12 fL Z2 
threshold provided the lowest RBC counts and the highest platelet counts, and was suspected to 
underestimate the true RBC count.  Since there was no significant difference between the Z2 
RBC counts at the three lower thresholds, the 10 fL lower threshold was selected as the 
reference method for RBC count, as it was suspected to include fewer platelets than the 8 fL 
lower threshold.  The reference method for MCV was a calculated value utilizing this RBC count.  
RBC counts and MCV values obtained from the different ADVIA species settings (equine, bovine, 
and goat) using the 25 EDTA-anticoagulated camelid whole blood samples were compared to 
the results from these reference methods in order to identify the most accurate ADVIA setting.  
Comparisons included the mean and median differences between the methods, the range of 
differences, and the proportion of ADVIA results falling within the allowable total error (TEa) 
range for the reference method.  Passing-Bablok regression analysis and Bland-Altman 
difference plots were also used to assess the bias of the ADVIA RBC and MCV measurements 
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compared to the reference methods.  No differences were observed between the ADVIA equine 
and camelid settings for any RBC or platelet values, and the equine setting results were used for 
all comparisons.   
 
Overall, the RBC counts on the ADVIA were lower than the 10 fL Z2 particle counts for whole 
blood, regardless of the species setting used.  However, the smallest mean and median 
differences between the two analyzers were observed when the ADVIA equine setting was used 
(-0.42 and -0.45 million/µL mean and median differences, respectively).  The difference between 
the equine and Z2 counts ranged from -1.39 to 0.63 million/µL.  The mean differences between 
the 10 fL Z2 count and the ADVIA bovine and goat channel counts were -2.46 and -1.41 
million/µL, respectively.  88% of the RBC counts on the ADVIA equine setting were within the TEa 
range for the reference method RBC count (i.e. within ±10% of the 10 fL count), while only 28% 
of the goat setting RBC counts and 0% of the bovine RBC counts were within this TEa range.  The 
Spearman rank correlation coefficients for the RBC counts measured by the ADVIA were very 
good (r≥0.92 for all three species settings), with no evidence of constant bias on any setting.  
Proportional bias for RBC counts was observed with the ADVIA bovine setting (Table 3).      
 
The reference method MCV was calculated based on a spun PCV and the RBC count from the 10 
fL Z2 threshold.  This calculated MCV was then compared to the MCV measured by each of the 
ADVIA species settings.  Overall, the MCV values measured by the ADVIA were higher than the 
calculated MCV, regardless of the species setting used.  However, similar to the results for the 
RBC counts above, the smallest mean and median differences between the two methods were 
observed with the ADVIA equine measurement (6.8 and 7.6 fL mean and median differences, 
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respectively).  The mean differences between the bovine and goat MCVs and the calculated 
MCV were 9.5 and 15.6 fL, respectively.  The ADVIA measured MCVs were within the TEa range 
of the calculated MCV (±7%) in 4% (equine) and 0% (bovine and goat) samples.  The correlation 
coefficients for the ADVIA MCV measurements were fair for the equine and bovine settings 
(r=0.65 and 0.67, respectively), however there was poor correlation between the MCV on the 
goat channel and the MCV calculated from the 10 fL Z2 RBC count (MCV=PCV/RBC x 10) (r=0.33).  
There was no evidence of constant bias for any of the ADVIA settings, however proportional bias 
was observed with all ADVIA MCV measurements.   
 
It would be impractical to suggest that clinical pathology laboratories use the 10 fL Z2 RBC count 
to calculate MCV on camelid samples, since a Z2 Coulter counter is not available in all labs.  
Therefore, a comparison was made between MCV calculated using the Z2 RBC count and the 
ADVIA equine RBC count.  The MCV calculated with the ADVIA equine RBC count was within the 
TEa range of the MCV calculated from the Z2 count 84% of the time, with a mean difference of 
only 1.7 fL.  Correlation between these values was good (r=0.70), with no evidence of constant 
or proportional bias.   
Assessment of bias between automated and manual methods 
In addition to the 25 EDTA-anticoagulated whole blood samples from the camelid population 
described above, EDTA whole blood samples were collected from 132 alpacas and llamas in East 
Tennessee for automated analysis on the ADVIA (equine, bovine, and goat settings), and manual 
analysis (spun PCV and blood smear review).  Results from this patient population were 
combined with the 25 samples from the population above to assess bias between automated 
and manual methods for hematocrit, MCHC, and platelet counts.    
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A spun PCV was considered the gold standard for measurement of volume of the percentage of 
red cells in blood.  Hct is related to PCV, but is determined by the ADVIA using a calculation 
involving absolute RBC count and measured MCV (Hct = (RBC x MCV)/10).  The correlation 
between the ADVIA Hct and spun PCV was good for all species settings (r>0.89), however both 
constant and proportional bias were observed with all settings.  Overall, the ADVIA Hct 
overestimated the manual PCV by a mean of 3.1% for the bovine setting, 6.5% for the equine 
setting, and 13.1% for the goat setting (Table 4).   
 
MCHC as reported by the ADVIA is also a calculated value: MCHC = (HGB/Hct) x 100.  Since the 
Hct is calculated by measurements likely to be inaccurate in camelids, and has already been 
shown to exhibit bias when compared to a spun PCV, bias assessments were also performed 
between the ADVIA MCHC values and an MCHC calculated using the spun PCV.  Hemoglobin 
concentration (HGB) is measured spectrophotometrically by a chemical reaction after RBC lysis 
in the ADVIA, and the result was the same for all species settings.  Correlation between the 
ADVIA MCHC and a calculated MCHC was poor for all species settings (r<0.4).  Constant and 
proportional bias were observed for the equine and goat settings.  Overall, the ADVIA’s MCHC 
values were lower than the calculated MCHC, with the smallest mean difference observed with 
the bovine setting and the largest difference with the goat setting.   
 
Platelet count and platelet indices are measured by the ADVIA through a combination of size 
and light scatter measurements.  The RBC/PLT reagent forms platelets into “pseudospheres,”25 
and there is no current evidence to suggest that camelid platelets would be resistant to this 
reaction compared to other species.  The platelet component distribution width (PCDW) was 
43 
 
also below 5.5 g/dL for a majority of the EDTA-anticoagulated samples from the first camelid 
population in this study, regardless of species setting, which has been described as supportive of 
adequate platelet sphering in dogs.78  Nonetheless, the ADVIA’s automated platelet counts were 
compared to a manual platelet estimate from a blood smear (average platelets per 1000x field 
multiplied by 20 = platelet estimate x103/µL), which was recorded for 62 of the camelids in the 
East Tennessee population.  When a range was reported for the platelet estimate, the mid-point 
of the range was used for comparison analysis.  There was no significant difference between the 
ADVIA’s platelet count using the equine setting and a manual platelet estimate (p=0.152), 
although a significant difference was observed between manual estimates and the automated 
counts from the bovine setting (p<0.0001).  Due to the low number of samples played back on 
the goat setting for this population, only 5 paired samples were available for comparison.  While 
the p-value for this comparison was marginally insignificant (p=0.063), the lack of overlap in the 
interquartile ranges for the two methods suggests that the difference in platelet counts 
between the goat channel and manual estimate may be clinically significant (Figure 7).   
No differences in any RBC or platelet values were observed between the ADVIA equine and 
camelid settings. 
Conclusion 
The results of this study demonstrate that camelid RBCs do not form isovolumetric spheres in 
vitro when exposed to the ADVIA RBC/PLT reagent, as do RBCs from other domestic mammal 
species such as the dog.  As a consequence, the methodology used to measure cell volume, 
identify cells as RBCs, and further characterize the RBCs based on hemoglobin concentration and 
percentage of cells per volume of blood in automated optical hematology analyzers will likely 
not provide accurate results for camelids.  The differences in RBC counts and indices between 
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various species settings of the ADVIA, and between the ADVIA and an impedance counter 
observed in this study support the hypothesis that accurate automated hematology analysis for 
camelid species is lacking.   
 
The Z2 Coulter counter uses an electrical impedance methodology which does not rely on cell 
shape, and only counts cells (particles) which fall between user-defined lower and upper volume 
thresholds.  One of the goals of this study was to identify the lower volume threshold that would 
provide the most accurate RBC counts in camelid blood – i.e. the threshold that includes the 
most RBCs in its count while excluding the majority of smaller particles (platelets).  Based on 
preliminary research (data not shown), and as might be expected, the Z2 particle count is 
highest with the lowest volume thresholds (4, 5, and 6 fL).  However, examination of the 
histograms provided by the Z2 counter at these thresholds suggested the possible inclusion of a 
second cell population, most likely platelets, and therefore a falsely increased RBC count.  RBC 
counts for the 8, 10, and 12 fL thresholds appeared to provide the highest, most accurate cell 
concentrations, and were therefore investigated further in the current study.  Of these three 
thresholds, the 8 fL threshold provided the highest RBC counts on whole blood and platelet-
poor RBC samples, as well as the highest platelet counts for PRP samples.  The differences in 
RBC and platelet counts between the different Z2 thresholds were statistically significant, 
however evaluation of the overlapping 95% confidence intervals for the means of these counts 
suggests that the differences may not be clinically significant (Figures 4-6).  Use of the 12 fL 
threshold resulted in the lowest platelet counts, however it was also the only evaluated 
threshold to provide a lower RBC count than the ADVIA on whole blood samples, suggesting that 
a proportion of camelid RBCs may be smaller than 12 fL, and be excluded from the total RBC 
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count.  Additionally, when the PRP platelet counts from all three Z2 thresholds were compared 
to the ADVIA platelet counts, statistically and clinically significant differences were observed, 
which were greater than the differences between the Z2 thresholds.  Given the relatively low 
concentration of platelets measured by the Z2 counter (tens of thousands per microliter vs. 
millions per microliter of RBCs), it was suspected that any interference by platelets in whole 
blood samples at these thresholds would result in minimal artificial increases in the RBC count.   
 
Since the Z2 counter is not a widely used hematology instrument in veterinary laboratories, a 
second goal of this study was to utilize the results obtained from our Z2 threshold analyses to 
inform accurate CBC methodology using more common instrumentation.  The ADVIA 120/2120 
optical hematology analyzers were designed for use with human blood and body fluids, but have 
been adapted for use with blood and fluids from various domestic mammal species.23,25,27,31  
ADVIA instruments are widely used by veterinary clinical pathology laboratories in both tertiary 
referral hospitals and commercial laboratories, all of which have the potential to see a large 
camelid caseload.  There is no designated species setting for camelid, camel, alpaca, or llama on 
the ADVIA, although anecdotal evidence suggests that the ADVIA’s equine setting provides the 
most accurate CBC results for these animals.28,39  The results of the present study support this 
claim with regards to the RBC count and thrombogram.  When RBC counts from various ADVIA 
species settings were compared to those measured by or derived from the 10 fL Z2 counts, the 
ADVIA equine setting resulted in the smallest mean differences, the largest proportion of results 
within the respective TEa guidelines, and often the strongest correlations.  The ADVIA bovine 
and goat settings were also included in this study based on the apparent correlation between 
their RBC volume thresholds and the expected MCV for camelid RBCs, however both of these 
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settings markedly underestimated the absolute RBC count and overestimated the platelet 
count.  While there is normally some degree of overlap in the RBC and platelet volume ranges 
regardless of species setting,25 the observed trends with the bovine and goat settings suggest 
that a substantial proportion of RBCs may be counted as platelets on these settings.  Given that 
the RBC volume (and hemoglobin concentration) thresholds for all of these ADVIA settings 
overlap substantially, it is suspected that the ADVIA uses additional criteria for identification and 
enumeration of RBCs, however it is uncertain what these factors are, or whether they are 
manageable at the user level. 
 
The linearity of the ADVIA for RBC concentrations above the manufacturer’s specified 
7,000,000/µL was also an initial concern, given that camelid species can have RBC counts 
approaching 18,000,000/µL in health.  However, the results of the dilution experiment with 
equine blood in this study indicate that the reportable range of the ADVIA extends to at least 
14,115,000 RBCs/µL.   There is no evidence to suggest that the analyzer would provide falsely 
decreased counts at higher RBC concentrations, although the possibility of a deviation from 
linearity at concentrations higher than those measured here cannot be excluded.    
Even with the ADVIA equine setting, there are still automated RBC values which will be 
inaccurate for camelids as a consequence of their lack of RBC sphering, including MCV, MCHC, 
and Hct.  Therefore, these values should be replaced by calculated MCV, calculated MCHC, and 
spun PCV.  Based on the results of these combined methods and the degree of bias with strictly 
automated methods (ADVIA), it appears that this combination is needed to provide the most 
accurate hematology data for camelid species.                     
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One important limitation to this study is that sample analysis was performed at two different 
institutions, which utilize different instruments and methods to measure the same hematology 
variables.  A spun PCV on the samples from Cornell was measured manually against a standard 
laminated reader card after centrifugation for 10 minutes in a high-speed microhematocrit 
centrifuge.  Meanwhile, the PCV values from the University of Tennessee were obtained using 
the “read” function of a low-speed centrifuge after 1 minute of centrifugation.  Analysis of the 
same whole blood sample by both methods will result in slightly different results based on 
preliminary data using canine blood (data not shown), however this is not expected to impact 
the conclusions of this study.  Additionally, the CBC results from the Cornell camelid population 
were obtained on an ADVIA 2120, while the majority of the results from the East Tennessee 
population were obtained on an ADVIA 120.  However, there are only minimal differences in the 
methodologies used by these analyzers to measure the RBC and platelet values of interest to 
this study,25 and this would not be expected to significantly affect data interpretation.   
 
Light microscopy was used in the current study to assess the ability of canine and camelid RBCs 
to undergo a sphering reaction in the ADVIA’s RBC/PLT reagent, which was sufficient for support 
of our hypothesis, but not ideal for truly evaluating three-dimensional sphere formation.  
Attempts were made in the early stages of this study to obtain scanning electron microscopy 
(SEM) images of the RBCs in both RBC/PLT reagent and normal saline, however the canine cells 
had lost their spherical shape in the time between exposure to the reagent and access to the 
SEM camera, appearing as biconcave discs.  Previous work suggests that although the sphering 
reaction in human RBCs takes place within 1 second with sodium dodecyl sulfate,75 
experimentally sphered RBCs begin to revert to a biconcave disc shape after approximately 8 
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hours.79  Since the time between incubation with the sphering reagent and obtaining SEM 
images in this study exceeded 8 hours, this most likely affected our ability to capture three-
dimensional evidence of canine RBC sphere formation.  Although the same fixative type and 
concentration were used in this study as had been previously described in a case of canine 
elliptocytosis,8 it seems possible that the more permanent nature of the abnormal RBC shape in 
that case allowed for retention of the shape for SEM image acquisition, compared to the 
experimental induction of abnormal RBC shape in the current study.         
 
Finally, although the results of this study show that current automated hematology analysis is 
inaccurate in camelid species, and provide methodology for more accurate determination of 
camelid RBC values in a clinical setting, the true values of many of these indices (i.e. MCV) are 
still unknown.  Additional research, potentially involving advanced imaging techniques, is 
needed to more fully characterize camelid RBCs and our ability to assess them.  
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CHAPTER II 
ENDOPARASITES AND ERYTHROCYTE VALUES 
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Abstract 
 
Background: Mycoplasma haemolamae and gastrointestinal nematodes can cause anemia in 
camelids. Parasite control programs aim to suppress parasite loads to subclinical levels without 
excessive deworming that promotes resistance, but there are few evidence-based guidelines for 
acceptable parasite loads in camelids.      
Objectives: In clinically healthy camelids: 1) Compare M. haemolamae PCR status and RBC 
values. 2) Determine the fecal egg count (FEC) threshold above which RBC values are 
consistently below the median of the reference interval.   
Methods: EDTA-anticoagulated blood was collected from 118 clinically healthy, non-anemic 
adult alpacas and llamas.  PCV was measured by centrifugation, RBC and HGB were measured by 
ADVIA, and Mycoplasma haemolamae was detected by real-time PCR.  The number of 
trichostrongyle eggs per gram (epg) was determined in a freshly collected fecal sample using the 
Modified McMaster’s test. Significant differences in RBC values between M. haemolamae 
positive and negative animals, and between various FEC thresholds, were assessed by 
independent T-test or Mann-Whitney rank sum test.      
Results: PCV, HGB, and RBC were not significantly different between M. haemolamae positive 
(N=41) and negative animals (P>0.5).  PCV, HGB, and RBC were significantly lower in animals 
with FEC>600epg (P<0.05).  For 10/10 animals with FEC>600epg, PCV, HGB, and RBC were below 
the median of the respective reference interval. 
Conclusions: Because positive M. haemolamae PCR is not associated with lower RBC values in 
healthy camelids, treatment for M. haemolamae may not be necessary in those animals.  
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FEC>600epg has a negative effect on RBC values, so maintaining FEC below that level is 
recommended in camelids.  
Background 
Mycoplasma haemolamae 
Mycoplasma haemolamae is a hemotropic bacterial organism (hemoplasma) that is known to 
cause anemia of variable severity in alpacas and llamas.  The mode of transmission of this 
pathogen is uncertain, although vector-borne transmission is suspected based on studies of 
similar hemoplasma organisms in other domestic mammals.  Iatrogenic, direct horizontal, and 
vertical modes of transmission have also been proposed.58,59 Many animals who test positive for 
this organism never show clinical signs, and it has been suggested that a majority of infections 
are subclinical, resulting in a carrier state that persists despite antibiotic treatment of infected 
animals.62  Anemia is the result of hemolysis, which primarily occurs extravascularly as splenic 
macrophages remove infected RBCs from circulation.  Clinical anemia is reported most often in 
infected animals who are immunosuppressed, stressed, debilitated, or suffering from a 
concurrent illness, although organisms can be observed on peripheral blood smears from both ill 
and clinically healthy animals as epicellular and extracellular ring-shaped structures.62   
 
The gold standard test for diagnosis of M. haemolamae is a real-time PCR (polymerase chain 
reaction) assay which is specific for detection of the organism’s 16S rRNA gene.53,54  However, 
bacteremia in infected animals is transient and cyclical, and it can therefore be difficult to 
identify M.haemolamae as an etiologic agent in cases of anemia.59  Previous studies have 
reported that infection with M. haemolamae (based on positive real-time PCR results) is not 
significantly associated with anemia (based on a PCV measurement below the lower reference 
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limit for the species);54,56 in one population the mean PCV of PCR-positive animals was higher 
than that of PCR-negative animals, although this difference was not statistically significant.56  In 
another study, one of two M. haemolamae positive alpacas was anemic based on PCV and 
clinical signs, however this individual also had an FEC of 2800 epg, suggesting that the M. 
haemolamae infection may not have been the only cause of anemia, if it was involved in the 
pathogenesis at all.61  
 
Given that PCV reference intervals for alpacas and llamas vary substantially between different 
laboratories, and that PCV is only one index of RBC mass, one goal of this study was to perform a 
more comprehensive assessment of the relationship between M. haemolamae PCR status and 
RBC values (including PCV, RBC count and HGB concentration). The hypothesis was that clinically 
healthy animals who are positive for M. haemolamae on real-time PCR would have significantly 
lower RBC value(s) compared to clinically healthy animals with negative PCR results.  If such a 
relationship exists, it might indicate a negative impact of M. haemolamae infection despite the 
lack of anemia or clinical illness, potentially explaining the increased susceptibility of infected 
animals to the development of clinical anemia in the presence of concurrent illness (e.g. heavy 
gastrointestinal nematode burdens) or immunosuppression.      
Gastrointestinal nematodes 
Gastrointestinal nematode infections are also a common cause of anemia in New World 
camelids.  Haemonchus contortus, a trichostrongylid nematode residing in the third gastric 
compartment (C3), is the most common and clinically significant endoparasite of alpacas and 
llamas.  H. contortus is also of clinical importance in small ruminants, in whom the parasite 
resides in the abomasum.66  Anemia is the result of blood loss, both through direct feeding of 
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the adult worm on the host’s blood supply, as well as irritation of the gastric mucosa.66  
Trichostrongylid infections can be diagnosed and semi-quantified with the fecal egg count test 
(FEC), which measures the number of trichostrongyle eggs per gram (epg) of feces.  However, 
this test cannot differentiate H. contortus eggs from other trichostrongyle eggs of similar size 
and morphology (e.g. Teladorsagia circumcincta, Trichostrongylus axei, etc).66  In addition, there 
are no established thresholds for defining clinically significant FECs in alpacas and llamas.  In one 
study performed in the southeastern United States, a majority of camelids with clinical anemia 
had an FEC >1000 epg,72 while a separate study in a population of alpacas from New Zealand 
identified 250 epg as a “high and clinically significant” egg count.61  This wide range of 
potentially significant values makes it difficult to base treatment decisions on FEC alone.   
 
The FAMACHA system (Faffa Malan Chart, named for its inventor, Dr. Francois “Faffa” Malan) 
has been validated as a clinical tool for assessing the degree of anemia due to H. contortus 
infection in South American camelids.72  In this system, an animal’s conjunctival mucous 
membrane color is evaluated side-by-side with a card showing varying shades of pink.  A score 
of 1 corresponds to bright pink/red membranes (normal, healthy) and a score of 5 corresponds 
to white membranes (severe anemia).  Deworming treatment is typically recommended for 
animals with scores of 3 or higher.   
 
FEC has been shown to be negatively correlated to PCV and other RBC values in clinically ill 
alpacas and llamas, and in naturally and experimentally infected sheep. 66,73,74 Additionally, 
experimental infection of sheep with Haemonchus sp. demonstrated a linear relationship 
between adult worm numbers, fecal egg counts, and blood loss.70  However, there has been no 
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published documentation of any correlation between FEC and RBC values in clinically healthy 
camelids.  Additionally, currently available tools used by practitioners and owners to identify 
animals in need of deworming treatment, such as the FAMACHA system, are only capable of 
identifying animals who are already anemic, potentially missing animals with high nematode 
burdens who are not yet clinically ill.  Conversely, deworming all animals in a herd regardless of 
their potential nematode burden is expensive and unnecessary, and promotes parasite 
resistance to deworming medications.  A second objective of this study was therefore to assess 
the relationship between FEC and RBC values (PCV, RBC, and HGB) in a population of clinically 
healthy (non-anemic) adult camelids, and to identify an FEC threshold above which RBC values 
are consistently (>50% of the time) below the median of their respective reference intervals (i.e. 
what is the FEC threshold at which a negative impact on RBC values is consistently observed?).  
Identification of this FEC threshold would provide additional guidance to owners and 
veterinarians in determining which animals could potentially benefit from deworming 
treatment, prior to the development of clinical anemia. 
Materials and Methods 
 
Patient population and sample collection 
Venous whole blood was collected from clinically healthy adult (≥ 1-year-old) alpacas and llamas 
from 12 farms in eastern Tennessee between July and October 2015.  Health was defined as a 
lack of significant abnormalities on physical examination as determined by an experienced 
veterinarian, a FAMACHA score of 3/5 or lower,72 a body condition score (BCS) of 2.5/5 or 
higher, and no history of illness or injury within the previous 3 months.  All examinations and 
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sample collections took place on the farms, and informed client consent was obtained for all 
procedures (approved UT IACUC protocol 2298-0914). 
 
Samples from a maximum of 12 animals were collected per farm.  Individual and herd histories 
were obtained, including species, age, sex, pregnancy/breeding status, housing, diet, vaccines, 
and parasite control practices.  After examination of each animal, a maximum of 10 mL of blood 
was collected by an experienced veterinarian from an external jugular vein using a 12 mL plastic 
syringe (Covidien LLC, Mansfield, MA) attached to a 20 gauge, 1.5-inch needle (Covidien LLC, 
Mansfield, MA).  The blood was placed in a 4 mL K2EDTA tube (Becton Dickinson, Franklin Lakes, 
NJ) and transported to the University of Tennessee clinical pathology laboratory in a cooler that 
was maintained at 4oC until arrival.  Blood samples were promptly analyzed (all analysis was 
performed within 6 hours of sample collection) by trained laboratory personnel.  Samples were 
evaluated for appropriate filling of the EDTA tube, and for clot formation and/or gross lipemia.  
Underfilled, clotted, and lipemic samples were excluded.  A CBC with reticulocyte count was 
performed on each sample using the equine setting of the ADVIA 120 hematology instrument 
according to laboratory standard operating procedures (SOP).   
 
Manual PCVs were determined following one minute of centrifugation in a rapid fixed angle 
head microhematocrit centrifuge (HemataStat II, EKF Diagnostics, Boerne, TX).  The centrifuge’s 
“read” function was used to determine the PCV; this function is calibrated for the 
microhematocrit’s centrifuge speed.  Proper microhematocrit centrifuge function was verified 
using an electronic tachometer prior to beginning the study, and a series of test centrifugations 
of camelid blood (data not shown) confirmed there is no significant difference in PCV with 
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centrifugation times longer than one minute.  ADVIA 120 and manual PCV analyses were 
performed by a licensed medical technologist trained in instrument use and following laboratory 
SOP.  The ADVIA 120 underwent daily quality control using 3-level QCM (OPTIpoint, Siemens 
Healthcare Diagnostics, Tarrytown, NY).   
 
A minimum of one blood smear was prepared from each sample, and reviewed by a medical 
technologist according to laboratory SOP.  Blood smear review included a leukocyte differential, 
RBC morphology review, and a manual platelet estimate.  Blood smears were also reviewed by a 
board-certified veterinary clinical pathologist. 
A fresh fecal sample was also collected digitally from the rectum of each animal by trained 
personnel, placed in an individual, clean plastic bag, and transported in a cooler to the UTVMC 
parasitology laboratory. 
M. haemolamae and FEC testing 
After CBC analysis, the remaining EDTA-anticoagulated whole blood from each animal was 
stored at -20oC for up to 30 days.  DNA extraction and real-time PCR for Mycoplasma 
haemolamae were performed, using previously described methods54 (Applied Biosystems 
StepOne™, ThermoFisher Scientific, Waltham, MA).  Positive and negative control samples were 
included in each run.  Individual samples were classified as positive or negative based on their CT 
(cycle threshold) value, with samples having a CT value less than or equal to 35.0 classified as 
positive.   
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Fecal egg counts were performed on each fecal sample using the Modified McMaster’s test, as 
has been previously described for alpacas and llamas.67  Briefly, 2 grams of feces were mixed 
with 28 mL of a sodium nitrate flotation solution with a specific gravity of 1.200.  The mixture 
was loaded into a McMaster’s slide, and examined under light microscopy after 5 minutes of 
flotation.  The number of strongylid eggs in both chambers was counted at 100x total 
magnification, and the total number counted in each sample was multiplied by 50 to obtain 
results in eggs per gram of feces (epg).  An egg count of 0 was reported as <50 epg.  Since FECs 
are based on visual identification of parasite eggs, it is not possible to distinguish between the 
various species of strongylid eggs with this method.  Therefore, nematode larval cultures were 
also performed on a subset of the fecal samples in order to further classify the strongylid species 
present. 
Statistical analysis   
Statistical analysis was performed using commercial software (MedCalc Statistical Software 
version 17.4 (MedCalc Software bvba, Ostend, Belgium; http://www.medcalc.org; 2017).  
Animals were classified as anemic or non-anemic based on having a PCV, RBC count, or HGB 
concentration below or above the lower limit, respectively, for the appropriate laboratory 
reference interval.   The sample population was also divided into two groups based on M. 
haemolamae PCR status: M. haemolamae-positive (Mhl-positive) and M. haemolamae-negative 
(Mhl-negative).  The distributions of RBC values (PCV, RBC, HGB) in both groups were assessed 
for normality using the D’Agostino-Pearson test.  The means/medians of the two groups were 
compared using the independent T-test or Mann-Whitney rank sum test.  Significance was 
based on a p-value <0.05 and lack of overlap in 95% confidence intervals for the mean/median.  
The sample population was also stratified into groups based on FEC: animals with FEC<450 epg, 
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600<FEC<1000 epg, and FEC≥1000 epg.  RBC values were compared between the different FEC 
strata using a one-way ANOVA or Kruskal-Wallis test, and significance was based on a p-
value<0.05 and lack of overlap in 95% confidence intervals for the mean/median.  Comparison 
of RBC values was also performed between Mhl-positive and Mhl-negative animals in the 
different FEC strata.  Receiver operator characteristic (ROC) curves were used to identify an FEC 
threshold with optimal sensitivity and specificity for predicting a negative effect on RBC values.   
 
Results 
 
Animals  
EDTA-anticoagulated whole blood and fecal samples were collected from 118 clinically healthy 
adult New World camelids.  There were 98 alpacas (55 females, 39 intact males, and 4 castrated 
males) and 20 llamas (13 females, 1 intact male, and 6 castrated males) in the study population.  
The alpacas ranged in age from 1-15 years (mean = 5.42 years), and the llamas ranged in age 
from 3-16 years (mean = 11 years).  There were 10 alpacas (3 females and 7 males) whose ages 
were unknown or not recorded.  Four animals were mildly anemic based on a PCV (n=2) or HGB 
concentration (n=2) below the lower limit of the laboratory reference interval (20% and 7.5 
g/dL, respectively); however, these animals were not clinically ill and had FAMACHA scores > 3 
due to study inclusion criteria.  RBC counts were within the reference interval for all animals, 
and PCV and HGB concentration were within their respective reference intervals for the 
remaining 114/118 animals.  A total of 41/118 animals (37 alpacas and 4 llamas) in this study 
population tested positive for M. haemolamae on real-time PCR, resulting in a 34.7% 
prevalence.  No Mycoplasma organisms were observed on blood smears from any animal.  FECs 
in this population ranged from <50 to 3200 epg, with a median and standard deviation of 100 ± 
59 
 
50 epg.  In addition to strongylid eggs, other nematode eggs (Nematodirus spp., Aonchotheca 
(Capillaria) spp.), coccidia (Eimeria spp.), and tapeworm eggs (Moniezia spp.) were noted in the 
McMaster chamber after fecal flotation; their presence was described qualitatively.  Larval 
cultures were performed on 18/118 fecal samples, and the L3 stage of H. contortus grew in all 
cultures.  Additional culture findings included Trichostrongylus spp. (n=4) and Nematodirus spp. 
(n=4).   
M. haemolamae and RBC values 
RBC values for Mhl-positive animals were consistently lower than those for Mhl-negative 
animals, however the differences between the group means for each value (PCV, RBC count, and 
HGB concentration) were not statistically significant.  The mean PCV of the Mhl-positive animals 
(n=41) was 32.1%, and the mean PCV of the Mhl-negative group (n=77) was 32.8% (p=0.526).  
The mean RBC count for the Mhl-positive group was 12.01 million/µL; the mean for the Mhl-
negative group was 12.02 million/µL (p=0.981).  The mean HGB concentration for the Mhl-
positive group was 12.76 g/dL, and the mean concentration for the Mhl-negative group was 
12.92 g/dL (p=0.725) (Figure 8).  Mean RBC values (PCV, RBC count, HGB) between Mhl-positive 
and Mhl-negative animals with an FEC>600 epg, and between Mhl-positive animals with CT 
values less than 30.0 and Mhl-negative animals were also compared, with no statistically 
significant differences observed (Figure 9).  
Fecal egg count and RBC values 
RBC values for animals in different FEC strata (<450 epg, between 600 and 1000 epg, and ≥1000 
epg) were compared.  A one-way ANOVA was used to compare the RBC counts between the 
strata.  The distribution of PCV and HGB values in the various strata were non-parametric, and 
the Kruskal-Wallis test was used for these comparisons.  The mean RBC counts for the different 
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FEC strata were 12.3 million/µL (<450 epg), 10.65 million/µL (600<FEC<1000 epg), and 9.70 
million/µL (≥1000 epg).  There was a significant difference between the lowest and highest 
strata (p=0.009), however neither of these two strata was significantly different from the middle 
stratum.  The median HGB concentrations for the different strata were 13.2 g/dL, 12.0 g/dL, and 
9.9 g/dL, respectively.  Similar to the findings for RBC count, there was a significant difference 
between the lower and upper strata (p=0.0075); the middle stratum was not significantly 
different from either the lower or upper strata.  The median PCVs for the different strata were 
33.5%, 30.0%, and 28.0%.  There were no significant difference between the PCVs of the various 
strata (p=0.105) (Figure 10).  Manual platelet estimates and refractometric plasma total protein 
concentrations were also compared between animals with an FEC <600 epg and those with an 
FEC >600 epg.  There were no statistically significant differences between platelet counts or 
total protein concentrations in animals with low vs. high FECs (data not shown).  
 
In concordance with the trend observed above of decreasing RBC values with increasing FECs, a 
scatterplot of HGB concentration vs. FEC revealed that all animals with an FEC greater than 600 
epg had a HGB concentration below the median of the camelid reference interval (Figure 11).  
This trend was also observed for RBC count and PCV in animals with an FEC greater than 600 
epg.   
 
Receiver operator characteristic (ROC) curves were used to identify the FEC threshold with the 
optimal combination of sensitivity and specificity for predicting RBC values below the median of 
their respective reference intervals.  At a FEC threshold of >600 epg, the sensitivity for a HGB 
concentration <13.2 g/dL was 100%.  Similarly, the sensitivity for a PCV below 33.5% was 100% 
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at an FEC threshold >600 epg.  The specificity for these HGB concentrations and PCV values at 
this threshold were 49.1% and 45.3%, respectively (Figure 12).  The specificity did not change 
substantially for either HGB or PCV with the use of different FEC thresholds (450, 700, or 1000 
epg).  The sensitivity for HGB and PCV was 82.4% and 85.4%, respectively, at a threshold of 450 
epg, and 100% at the 700 and 1000 epg thresholds. 
Conclusion 
This study found no statistically significant differences in mean RBC values (PCV, HGB, RBC 
count) between Mycoplasma haemolamae positive and negative animals from a population of 
clinically healthy, adult alpacas and llamas.  This lack of relationship between RBC values and M. 
haemolamae PCR status was independent of both the degree of M. haemolamae positivity 
(based on CT value) and of fecal egg count.  The results of this study support the findings of 
previous research, suggesting that the majority of cases of M. haemolamae infections are 
subclinical and that antimicrobial treatment is likely not warranted based on PCR status 
alone.56,62  However, our hypothesis that there would be a negative correlation between M. 
haemolamae PCR status and RBC values in clinically healthy adult camelids was rejected.  The 
presence of such a correlation would have suggested that even in a subclinical state, the 
bacteria could have a negative impact on the animal’s RBC mass and/or oxygen-carrying ability, 
thereby increasing susceptibility to the development of clinical anemia in the presence of 
concurrent disease (i.e. high gastrointestinal nematode burden, malnutrition, etc).   
 
The prevalence of M. haemolamae infection in our study population (34.7%) is higher than that 
reported in previous prevalence studies for this organism in other geographic areas. 56,60,61 This 
increased prevalence may reflect the subtropical latitude at which the current population 
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resides (possibly supporting vector-borne disease transmission), or different husbandry 
practices for camelids in various parts of the world.  The average number of Mhl-positive 
animals per farm in this study was 3, however the proportion of affected animals on a given 
farm ranged from 0-100%, suggesting the influence of different husbandry practices on disease 
transmission and prevalence.  Given the relatively high prevalence of M. haemolamae infection 
and the overall size of the sample population, it is unlikely that rejection of our hypothesis was 
the result of insufficient statistical power.  However, the lack of relationship with RBC values 
observed in this study may reflect the exclusion of animals with high FAMACHA scores and/or 
low body condition scores.  Even though separation of Mhl-positive animals based on CT value 
did not demonstrate significant differences in RBC values compared to Mhl-negative animals, it 
is possible that use of a quantitative PCR assay (instead of the semi-quantitative assay used in 
the current study) may have allowed for increased sensitivity in detection of changes in RBC 
mass in animals with higher DNA copy numbers.  Additionally, the exclusion of alpacas and 
llamas less than 1 year old from the current study precluded evaluation of the potential effects 
of M. haemolamae infection on RBC values in young animals.  Given that cases of clinical anemia 
have been reported in young, potentially immunocompromised camelids,52,59 the possibility that 
negative RBC effects may be more likely to be observed in association with infection in animals 
less than 1 year old should be considered for future study.  Ultimately, further study is also 
needed to more fully comprehend the subclinical nature of M. haemolamae infections in adult 
camelids, and the factors which allow for the development of clinical hemolytic anemia.   
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The results of the present study do demonstrate a trend of decreasing RBC values with 
increasing FECs, and that clinically healthy animals with high FECs (>1000 epg) are statistically 
more likely to have lower RBC counts and HGB concentration than animals with FECs <450 epg.  
Additionally, an FEC threshold of 600 epg has excellent sensitivity and fair specificity, in this 
population of clinically healthy camelids, for predicting a PCV and HGB concentration below the 
median of the reference interval.  Alpaca and llama owners and veterinarians currently have 
limited tools available for assessing the clinical significance of gastrointestinal parasite burdens 
and the need for parasite treatment.  The goal of deworming is to prevent and/or treat the 
effects of clinical blood loss anemia in at-risk animals, while avoiding the promotion of parasite 
resistance to the anthelminthic medications.  However, owners and veterinarians are often 
faced with the limited options of either deworming clinically anemic animals (as identified by a 
FAMACHA score),72 or prophylactically deworming all animals on the farm (or a random subset) 
in hopes of reaching those animals who are most likely to develop clinical disease and/or shed 
large numbers of eggs.  The identification of a FEC threshold above which RBC values are likely 
to be negatively affected should therefore aid substantially in making treatment decisions, 
allowing for targeted deworming of those animals with clinically significant nematode burdens.    
However, FEC testing via the Modified McMaster’s test is inherently of low analytical sensitivity, 
as each strongylid egg counted is interpreted as representing 50 eggs.  The lowest obtainable 
FEC is therefore <50 epg, and all egg counts are expressed in intervals of 50; this test is 
therefore only semi-quantitative.  FEC testing is also relatively imprecise, since counts can vary 
substantially between observers, between different portions of the same fecal sample, and with 
variations in the concentration of the flotation solution, sample dilution, and volume of the 
counting chamber.69  Additionally, the correlation between trichostrongylid egg numbers in 
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feces and adult worm burden of a particular species (i.e. Haemonchus spp.) in the GI tract is 
uncertain.  The FEC test as performed in this study is relatively simple in its methodology, and 
has the potential to be replicated on-farm by alpaca and llama owners; however, additional 
research assessing the precision and accuracy of owner-performed FECs compared to those 
performed by diagnostic laboratory personnel would be required prior to implementation of the 
use of these diagnostic guidelines for animal owners.  Additionally, the present study only 
allowed for assessment of the association between FEC and RBC values at a single point in time.  
It would therefore be useful to perform a prospective cohort study in the future, in order to 
determine whether an FEC over 600 epg is truly predictive for the development of anemia.  The 
inclusion of young camelids (less than 1 year old) in any future studies would also be helpful in 
assessing the effects of gastrointestinal nematodes on RBC values in this age group.   
 
An important limitation of both parts of this study is the inability to exclude the effects of other 
factors (internal and external) on the measured RBC values.  RBC values are analyzed as a 
reflection of an animal’s overall RBC mass, which is affected by multiple factors including age, 
hydration status, nutrient balance, and renal and bone marrow function.  Despite the presence 
of known causes of anemia (Mycoplasma spp., gastrointestinal nematodes), it is difficult to 
attribute changes in RBC values (or lack thereof) solely to the presence or absence of these 
organisms.  For example, decreased RBC values may reflect iron deficiency, or the effects of 
inflammation on erythropoiesis, rather than direct blood loss from endoparasites.     
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In conclusion, the results of the present study confirm the findings of previous studies which 
demonstrate a lack of association between M. haemolamae infection and PCV in alpacas and 
llamas, and expand these findings to also include a lack of association with HGB concentration or 
RBC count.  Overall, this suggests that treatment of clinically healthy M. haemolamae PCR-
positive animals is not warranted, although M. haemolamae infection cannot be ruled out as a 
contributing cause to the development of clinical anemia in these camelids.  Finally, with 
additional research and method validation, the use of an FEC threshold of <600 epg in clinically 
healthy alpacas and llamas may provide one component for guiding deworming strategies.  
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CONCLUSION 
 
The present studies provide, to the author’s knowledge, the first report of validated hematology 
methods for camelid species, as well as the first set of evidence supporting the existence of an 
acceptable endoparasite load in camelids.  Camelid erythrocytes do not sphere when mixed with 
ADVIA sphering reagent, making some RBC values inaccurate.  Based on our results, the 
recommended method for reporting the erythrogram and thrombogram from camelids using 
the ADVIA 120 is as follows: 
• RBC count: ADVIA equine setting 
• HGB concentration: ADVIA equine setting 
• Volume percentage of RBCs in whole blood: PCV 
• MCV: Calculated (PCV divided by ADVIA equine setting RBC count multiplied by 10) 
• MCHC: Calculated (ADVIA equine setting HGB divided by PCV multiplied by 100) 
• Platelet count: ADVIA equine setting 
RBC values are not significantly different between M. haemolamae positive and negative 
animals, but are significantly lower in animals with FEC>600epg.  For all animals with 
FEC>600epg, RBC values are below the medians of the reference intervals.  Positive M. 
haemolamae PCR is not associated with lower RBC values in healthy camelids, consistent with 
previous reports that most infections are subclinical.  Maintaining FEC below 600 epg is 
recommended in camelids.   
67 
 
REFERENCES 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
68 
 
1. Tornquist SJ. Clinical pathology of llamas and alpacas. Vet Clin North Am Food Anim 
Pract. 2009;25(2):311-322. 
2. Tornquist SJ, Cebra C. Clinical Pathology. In: Llama and Alpaca Care.2014:338-350. 
3. Vap L, Bohn AA. Hematology of camelids. Vet Clin North Am Exot Anim Pract. 
2015;18(1):41-49. 
4. Raskin R, Wardrop K. Species specific hematology. In. Schalm’s Veterinary Hematology, 
6th edition, Wiley-Blackwell, Iowa2010:797-1018. 
5. Omorphos S, Hawkey CM, Rice-Evans C. The elliptocyte: a study of the relationship 
between cell shape and membrane structure using the camelid erythrocyte as a model. 
Comparative Biochemistry and Physiology Part B: Comparative Biochemistry. 
1989;94(4):789-795. 
6. Harvey JW. Chapter 7 - The Erythrocyte: Physiology, Metabolism, and Biochemical 
Disorders. In: Clinical Biochemistry of Domestic Animals (Sixth Edition). San Diego: 
Academic Press; 2008:173-240. 
7. Silveira P, Cynober T, Dhermy D, Mohandas N, Tchernia G. Red blood cell abnormalities 
in hereditary elliptocytosis and their relevance to variable clinical expression. American 
Journal of Clinical Pathology. 1997;108(4):391-399. 
8. Di Terlizzi R, Gallagher PG, Mohandas N, et al. Canine elliptocytosis due to a mutant β-
spectrin. Veterinary Clinical Pathology. 2009;38(1):52-58. 
9. Gulliver G. Observations on the Sizes and Shapes of the Red Corpuscles of the Blood of 
Vertebrates. 1875. 
10. Jain N, Keeton K. Morphology of camel and llama erythrocytes as viewed with the 
scanning electron microscope. British Veterinary Journal. 1974;130(3):288-291. 
11. Rana J, Bhardwaj R, Singh R. Morphological studies of erythrocytes in different animal 
species. INDIAN VETERINARY JOURNAL. 1992;69(6):505-507. 
12. Lewis JH. Comparative hematology—studies on camelidae. Comparative Biochemistry 
and Physiology Part A: Physiology. 1976;55(4):367-371. 
13. Bogner P, Miseta A, Berente Z, Schwarcz A, Kotek G, Repa I. Osmotic and diffusive 
properties of intracellular water in camel erythrocytes: effect of hemoglobin 
crowdedness. Cell Biol Int. 2005;29(9):731-736. 
14. Bogner P, Csutora P, Cameron IL, Wheatley DN, Miseta A. Augmented water binding and 
low cellular water content in erythrocytes of camel and camelids. Biophysical Journal. 
1998;75(6):3085-3091. 
15. Jain N. MEASUREMENT, INTERPRETATION, FACTORS INVOLVED, AND MECHANISM OF 
OSMOTIC FRAGILITY WITH OBSERVATIONS ON ANIMAL ERYTHROCYTES. Veterinary 
Clinical Pathology. 1972;1(3):3-24. 
16. Schroter R, Filali RZ, Brain A, Jeffrey P, Robertshaw D. Influence of dehydration and 
watering on camel red cell size: a scanning electron microscopic study. Respiration 
Physiology. 1990;81(3):381-390. 
17. Eitan A, Aloni B, Livne A. Unique properties of the camel erythrocyte membrane: II. 
Organization of membrane proteins. Biochimica et Biophysica Acta (BBA)-
Biomembranes. 1976;426(4):647-658. 
18. Smith JE, Mohandas N, Shohet SB. Variability in erythrocyte deformability among 
various mammals. American Journal of Physiology-Heart and Circulatory Physiology. 
1979;236(5):H725-H730. 
69 
 
19. McPherson RA, Sawyer WH, Tilley L. Band 3 mobility in camelid elliptocytes: implications 
for erythrocyte shape. Biochemistry. 1993;32(26):6696-6702. 
20. Khodadad JK, Weinstein RS. The band 3-rich membrane of llama erythrocytes: studies 
on cell shape and the organization of membrane proteins. Journal of Membrane Biology. 
1983;72(3):161-171. 
21. Poyart C, Wajcman H, Kister J. Molecular adaptation of hemoglobin function in 
mammals. Respiration Physiology. 1992;90(1):3-17. 
22. Bartels H, Hilpert P, Barbey K, et al. Respiratory functions of blood of the yak, llama, 
camel, Dybowski deer, and African elephant. American Journal of Physiology--Legacy 
Content. 1963;205(2):331-336. 
23. Moritz A, Becker M. Automated hematology systems. In. Schalm's Veterinary 
Hematology. 6th edn. Edited by Weiss DJ, Wardrop KJ: Ames, Iowa: Wiley-
Blackwell2010:1054-1056. 
24. Tycko D, Metz M, Epstein E, Grinbaum A. Flow-cytometric light scattering measurement 
of red blood cell volume and hemoglobin concentration. Applied Optics. 
1985;24(9):1355-1365. 
25. Harris N, Kunicka J, Kratz A. The ADVIA 2120 hematology system: flow cytometry-based 
analysis of blood and body fluids in the routine hematology laboratory. Laboratory 
Hematology: Official Publication of the International Society for Laboratory Hematology. 
2005;11(1):47-61. 
26. Perez-Ecija A, Gonzalez-De Cara CA, Aguilera-Aguilera R, Estepa JC, Rubio MD, Mendoza 
FJ. Comparison of donkey hemogram using the LaserCyte hematology analyzer, an 
impedance system, and a manual method. Vet Clin Pathol. 2014;43(4):525-537. 
27. Giordano A, Rossi G, Pieralisi C, Paltrinieri S. Evaluation of equine hemograms using the 
ADVIA 120 as compared with an impedance counter and manual differential count. 
Veterinary Clinical Pathology. 2008;37(1):21-30. 
28. Dawson DR, DeFrancisco RJ, Stokol T. Reference intervals for hematologic and 
coagulation tests in adult alpacas (Vicugna pacos). Vet Clin Pathol. 2011;40(4):504-512. 
29. Weiser M, Fettman M, Van Houten D, Johnson L, Garry F. Characterization of 
erythrocytic indices and serum iron values in healthy llamas. American Journal of 
Veterinary Research. 1992;53(10):1776-1779. 
30. Hajduk P. Haematological reference values for alpacas. Australian Veterinary Journal. 
1992;69(4):89-90. 
31. Siemens. Advia 120 Hematology System, Performance Specifications.  
https://www.healthcare.siemens.com/hematology/systems/advia-120-hematology-
system/technical-specifications. Accessed January 3, 2018. 
32. Siemens. Module 4: ADVIA 120 Methods.  
33. Latimer P. Light scattering by ellipsoids. Journal of Colloid and Interface Science. 
1975;53(1):102-109. 
34. Kinnunen M, Kauppila A, Karmenyan A, Myllylä R. Effect of the size and shape of a red 
blood cell on elastic light scattering properties at the single-cell level. Biomedical Optics 
Express. 2011;2(7):1803-1814. 
35. Borovoi AG, Naats EI, Oppel UG. Scattering of light by a red blood cell. Journal of 
Biomedical Optics. 1998;3(3):364-373. 
70 
 
36. Mohandas N, Kim Y, Tycko D, Orlik J, Wyatt J, Groner W. Accurate and independent 
measurement of volume and hemoglobin concentration of individual red cells by laser 
light scattering. Blood. 1986;68(2):506-513. 
37. Mohandas N, Clark MR, Kissinger S, Bayer C, Shohet SB. Inaccuracies associated with the 
automated measurement of mean cell hemoglobin concentration in dehydrated cells. 
Blood. 1980;56(1):125-128. 
38. Rice-Evans C, Omorphos S, White JM. The effects of hydrazine on sickle cells. Biochimica 
et Biophysica Acta (BBA)-Biomembranes. 1982;691(2):367-371. 
39. Dawson Soto DR, Stokol T, DeFrancisco R. Clarification of methods for hematologic 
reference intervals in adult alpacas. Veterinary Clinical Pathology. 2014;43(1):1-1. 
40. Pan L-L, Chen C-M, Huang W-T, Sun C-K. Enhanced Accuracy of Optical Platelet Counts in 
Microcytic Anemia. Laboratory Medicine. 2014;45(1):32-36. 
41. Grimes CN, Fry MM. Customization of Advia 120 thresholds for canine erythrocyte 
volume and hemoglobin concentration, and effects on morphology flagging results. The 
Canadian Veterinary Journal. 2014;55(12):1173. 
42. Beckman Coulter, Inc. Z Series Coulter counter: cell counting and sizing. Fullerton, CA. 
2004. 
43. England JM. Reference method for the enumeration of erythrocytes and leucocytes. 
Clinical & Laboratory Haematology. 1994;16(2):131-138. 
44. Chernyshev AV, Tarasov PA, Semianov KA, Nekrasov VM, Hoekstra AG, Maltsev VP. 
Erythrocyte lysis in isotonic solution of ammonium chloride: Theoretical modeling and 
experimental verification. Journal of Theoretical Biology. 2008;251(1):93-107. 
45. Johnson J, Edmondson M, Walz P, Marley M, Givens M. Comparison of clinical, 
hematological, and virological findings in alpacas (Lama pacos) inoculated with bovine 
viral diarrhea virus isolates of alpaca or bovine origin. Small Ruminant Research. 
2010;94(1):66-72. 
46. Topliff CL, Smith DR, Clowser SL, et al. Prevalence of bovine viral diarrhea virus 
infections in alpacas in the United States. Journal of the American Veterinary Medical 
Association. 2009;234(4):519-529. 
47. Abdurahman OAS, Saad AM. Characterization of camel leukocytes by flow cytometry 
and microscopic evaluation of granulocyte phagocytosis of fluorescent bacteria. 
Transboundary and Emerging Diseases. 1996;43(1-10):111-117. 
48. Killeen AA, Long T, Souers R, Styer P, Ventura CB, Klee GG. Verifying performance 
characteristics of quantitative analytical systems: calibration verification, linearity, and 
analytical measurement range. Archives of Pathology & Laboratory Medicine. 
2014;138(9):1173-1181. 
49. Serebrennikova YM, Huffman DE, Garcia-Rubio LH. Characterization of red blood cells 
with multiwavelength transmission spectroscopy. Biomed Res Int. 2015;2015:382641. 
50. Tomaiuolo G, Rossi D, Caserta S, Cesarelli M, Guido S. Comparison of two flow-based 
imaging methods to measure individual red blood cell area and volume. Cytometry A. 
2012;81(12):1040-1047. 
51. Messick JB. Hemotrophic mycoplasmas (hemoplasmas): a review and new insights into 
pathogenic potential. Veterinary Clinical Pathology. 2004;33(1):2-13. 
52. Allison R, Meinkoth J. Anemia caused by rickettsia, mycoplasma, and protozoa. Schalm’s 
Veterinary Hematology 6th Ed Wiley-Blackwell. 2010. 
71 
 
53. Guimaraes AM, Toth B, Santos AP, do Nascimento NC, Kritchevsky JE, Messick JB. 
Genome sequence of “Candidatus Mycoplasma haemolamae” strain purdue, a red 
blood cell pathogen of alpacas (Vicugna pacos) and llamas (Lama glama). Journal of 
Bacteriology. 2012;194(22):6312-6313. 
54. Meli ML, Kaufmann C, Zanolari P, et al. Development and application of a real-time 
TaqMan((R)) qPCR assay for detection and quantification of 'Candidatus Mycoplasma 
haemolamae' in South American camelids. Vet Microbiol. 2010;146(3-4):290-294. 
55. Ghazisaeedi F, Atyabi N, Zahrai Salehi T, et al. A molecular study of hemotropic 
mycoplasmas (hemoplasmas) in cats in Iran. Vet Clin Pathol. 2014;43(3):381-386. 
56. Tornquist SJ, Boeder L, Rios-Phillips C, Alarcon V. Prevalence of Mycoplasma 
haemolamae infection in Peruvian and Chilean llamas and alpacas. Journal of Veterinary 
Diagnostic Investigation. 2010;22(5):766-769. 
57. Reagan W, Garry F, Thrall M, Colgan S, Hutchison J, Weiser M. The clinicopathologic, 
light, and scanning electron microscopic features of eperythrozoonosis in four naturally 
infected llamas. Veterinary Pathology. 1990;27(6):426-431. 
58. Fisher DJ, Zinkl JG. Eperythrozoonosis in a One-Day-Old Llama. Veterinary Clinical 
Pathology. 1996;25(3):93-94. 
59. Almy FS, Ladd SM, Sponenberg DP, Crisman MV, Messick JB. Mycoplasma haemolamae 
infection in a 4-day-old cria: support for in utero transmission by use of a polymerase 
chain reaction assay. The Canadian Veterinary Journal. 2006;47(3):229. 
60. Crosse P, Ayling R, Whitehead C, et al. First detection of 'Candidatus Mycoplasma 
haemolamae' infection in alpacas in England. Vet Rec. 2012;171(3):71. 
61. Dittmer KE, Hinkson JA, Dwyer C, Adlington B, van Andel M. Prevalence of Candidatus 
Mycoplasma haemolamae, bovine viral diarrhoea virus, and gastrointestinal parasitism 
in a sample of adult New Zealand alpaca (Vicugna pacos). N Z Vet J. 2018;66(1):9-15. 
62. Tornquist SJ, Boeder LJ, Cebra CK, Messick J. Use of a polymerase chain reaction assay to 
study response to oxytetracycline treatment in experimental Candidatus Mycoplasma 
haemolamae infection in alpacas. American Journal of Veterinary Research. 
2009;70(9):1102-1107. 
63. Ballweber LR. Ecto- and endoparasites of new world camelids. Vet Clin North Am Food 
Anim Pract. 2009;25(2):295-310. 
64. Cafrune MaM, Aguirre DH, Rickard LG. First report of Lamanema chavezi (Nematoda: 
Trichostrongyloidea) in llamas (Lama glama) from Argentina. Veterinary Parasitology. 
2001;97(2):165-168. 
65. Dargie J, Allonby E. Pathophysiology of single and challenge infections of Haemonchus 
contortus in Merino sheep: Studies on red cell kinetics and the “self-cure” phenomenon. 
International Journal for Parasitology. 1975;5(2):147-157. 
66. Edwards EE, Garner BC, Williamson LH, Storey BE, Sakamoto K. Pathology of 
Haemonchus contortus in New World camelids in the southeastern United States: a 
retrospective review. J Vet Diagn Invest. 2016;28(2):105-109. 
67. Cebra CK, Stang BV. Comparison of methods to detect gastrointestinal parasites in 
llamas and alpacas. Journal of the American Veterinary Medical Association. 
2008;232(5):733-741. 
68. Galvan N, Middleton JR, Nagy DW, Schultz LG, Schaeffer JW. Anthelmintic resistance in a 
herd of alpacas (Vicugna pacos). The Canadian Veterinary Journal. 2012;53(12):1310. 
72 
 
69. Cringoli G, Rinaldi L, Veneziano V, Capelli G, Scala A. The influence of flotation solution, 
sample dilution and the choice of McMaster slide area (volume) on the reliability of the 
McMaster technique in estimating the faecal egg counts of gastrointestinal strongyles 
and Dicrocoelium dendriticum in sheep. Vet Parasitol. 2004;123(1-2):121-131. 
70. Le Jambre L. Relationship of blood loss to worm numbers, biomass and egg production 
in Haemonchus infected sheep. International Journal for Parasitology. 1995;25(3):269-
273. 
71. Burke JM, Kaplan RM, Miller JE, et al. Accuracy of the FAMACHA system for on-farm use 
by sheep and goat producers in the southeastern United States. Vet Parasitol. 
2007;147(1-2):89-95. 
72. Storey BE, Williamson LH, Howell SB, et al. Validation of the FAMACHA(c) system in 
South American camelids. Vet Parasitol. 2017;243:85-91. 
73. Di Loria A, Veneziano V, Piantedosi D, et al. Evaluation of the FAMACHA system for 
detecting the severity of anaemia in sheep from southern Italy. Vet Parasitol. 
2009;161(1-2):53-59. 
74. Vanimisetti H, Andrew S, Zajac A, Notter D. Inheritance of fecal egg count and packed 
cell volume and their relationship with production traits in sheep infected with. Journal 
of Animal Science. 2004;82(6):1602-1611. 
75. Kim YR, Ornstein L. Isovolumetric sphering of erythrocytes for more accurate and 
precise cell volume measurement by flow cytometry. Cytometry Part A. 1983;3(6):419-
427. 
76. Semevolos SA, Youngblood CD, Grissom SK, Gorman ME, Larson MK. Evaluation of two 
platelet-rich plasma processing methods and two platelet-activation techniques for use 
in llamas and alpacas. American Journal of Veterinary Research. 2016;77(11):1288-1294. 
77. Nabity MB, Harr KE, Camus MS, Flatland B, Vap Linda M. ASVCP guidelines: Allowable 
total error hematology. Veterinary Clinical Pathology. 2018;47(1):9-21. 
78. Stokol T, Erb HN. A comparison of platelet parameters in EDTA-and citrate-
anticoagulated blood in dogs. Veterinary Clinical Pathology. 2007;36(2):148-154. 
79. Rogausch H. Time-dependent reaction of human red cell deformability on sphering 
agents. Pflügers Archiv. 1976;362(2):121-126. 
 
 
 
 
 
 
 
 
 
 
 
 
 
73 
 
APPENDIX 
 
74 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Methodology for analysis of whole blood, PRP, and RBCs 
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Figure 2. Light microscopic images of RBC sphering reactions 
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Table 1. RBC linearity data: measured and expected RBC counts 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Dilution (plasma:RBC) Average measured RBC 
count (x106/µL) 
Expected RBC count 
(x106/µL) 
Plasma 0.33 0 
4:1 3.17 2.82 
3:2 5.32 5.65 
2:3 8.58 8.47 
1:4 11.11 11.30 
RBC 14.12 14.12 
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Figure 3. Correlation scatter plot with regression line for equine RBC dilutions 
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Figure 4. A) Comparison of mean (black lines) ± 95% CI (blue lines) for Z2 counts on camelid whole blood B) Comparison of mean ± 95% CI 
for Z2 counts and ADVIA RBC counts on camelid whole blood  
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Table 2. Summary of RBC and platelet counts for whole blood, platelet-poor RBCs, PRP, and PPP. 
NA=not applicable; ND=not determined. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 PCV 
(%) 
ADVIA (equine) Z2 particle count 
RBC 
(x106/µL) 
PLT 
(x103/µL) 
8 fL 10 fL 12 fL 
Whole blood    (x106/µL) 
Llama 1 26 10.73 442 11.21 10.77 10.03 
Llama 2 26 11.02 445 10.87 10.55 10.38 
Llama 3 22 6.73 349 6.44 6.28 6.25 
Llama 4 27 9.82 384 9.82 9.63 9.14 
Platelet-poor 
RBCs 
   (x106/µL) 
Llama 1 26 10.52 29 12.29 10.75 11.42 
Llama 2 24 11.00 33 10.41 10.14 9.51 
Llama 3 21 6.47 11 5.78 5.71 6.12 
Llama 4 20 7.64 39 7.78 7.74 7.41 
PRP    (x103/µL) 
Llama 1 NA 0.06 486 125 75 35 
Llama 2 NA 0.03 405 90 70 55 
Llama 3 NA 0.02 243 95 35 25 
Llama 4 NA 0.02 328 120 55 30 
PPP    (x103/µL) 
Llama 1 NA 0 ND    
Llama 2 NA 0 16    
Llama 3 NA 0 4    
Llama 4 NA 0 6    
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Figure 5. Comparison of mean (black line) ± 95% CI (blue lines) for Z2 counts on platelet-poor 
RBCs 
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Figure 6. Comparison of mean (black line) ± 95% CI (blue lines) for ADVIA platelet counts (equine 
setting) and Z2 counts on PRP 
 
 
0
100
200
300
400
500
600
700
Pl
at
el
et
 c
ou
nt
 (t
ho
us
an
ds
/u
L)
ADVIA_equine Z2_8 Z2_10 Z2_12
82 
 
Table 3. Method comparison summary of RBC count and MCV between ADVIA and Z2 
 
     Passing-Bablok regression Bland-Altman  
Analyte Test 
method 
Comparative 
method 
N R y-int 95% CI Constant 
bias? 
Slope 95% 
CI 
Proportional 
bias? 
Mean 
diff. 
±1.96 
SD 
% of results 
within TEa of 
comparative 
method 
RBC 
(x106/uL) 
ADVIA 
equine 
Z2 10 fL 25 0.96 -0.512 -1.631 
to 
0.468 
No 1.01 0.922 
to 
1.11 
No -0.42 -1.47 to 
0.64 
88% 
RBC  
(x106/uL)  
ADVIA 
bovine 
Z2 10 fL 25 0.92 -0.149 -0.856 
to 
0.973 
No 0.785 0.687 
to 
0.873 
Yes -2.5 -4.3 to -
0.7 
0% 
RBC  
(x106/uL 
ADVIA 
goat 
Z2 10 fL 25 0.94 -0.764 -1.92 
to 
0.338 
No 0.943 0.840 
to 
1.07 
No -1.41 -2.88 to 
0.06 
28% 
MCV (fL) ADVIA 
equine 
Calculated 
MCV from Z2 
10 fL 
25 0.65 -2.542 -11.99 
to 
5.314 
No 1.426 1.10 
to 
1.828 
Yes 6.8 1.3 to 
12.3 
4% 
MCV (fL) ADVIA 
bovine 
Calculated 
MCV from Z2 
10 fL 
25 0.67 -3.01 -18.93 
to 
4.662 
No 1.575 1.246 
to 
2.232 
Yes 9.5 2.8 to 
16.2 
0% 
MCV (fL) ADVIA 
goat 
Calculated 
MCV from Z2 
10 fL 
25 0.33 -34.11 -125.5 
to 
3.621 
No 3.12 1.503 
to 
7.008 
Yes 15.6 2.3 to 
28.9 
0% 
MCV (fL) Calc. 
from 
ADVIA 
equine 
Calculated 
MCV from Z2 
10 fL 
25 0.70 -3.37 -13.34 
to 
1.718 
No 1.181 0.972 
to 
1.596 
No 1.7 -5.0 to 
8.3 
84% 
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Table 4. Method comparison summary of Hct and MCHC between automated and manual methods 
 
 
 
 
 
 
 
 
     Passing-Bablok regression Bland-Altman  
Analyte Test 
metho
d 
Comparati
ve 
method 
N R y-int 95% CI Con
stan
t 
bias
? 
Slope 95% CI Proporti
onal 
bias? 
Mean 
diff. 
± 1.96 
SD 
% of results 
within TEa of 
comparative 
method 
Hct (%) ADVIA 
equine 
PCV 156 0.89 -4.117 -6.375 to 
-2.107 
Yes 1.378 1.316 
to 
1.450 
Yes 6.5 -6.9 to 
20.0 
5% 
Hct (%) ADVIA 
bovine 
PCV 155 0.94 -3.956 -6.30 to   
-1.80 
Yes 1.222 1.150 
to 1.30 
Yes 3.1 -3.0 to 
9.1 
46% 
Hct (%) ADVIA 
goat 
PCV 38 0.92 -10.60 -17.350 
to -4.750 
Yes 1.80 1.60 to 
2.050 
Yes 13.1 -4.2 to 
30.5 
5% 
MCHC 
(g/dL) 
ADVIA 
equine 
Calculated 
MCHC 
from PCV 
155 0.21 20.98
4 
17.567 to 
24.006 
Yes 0.266 0.189 
to 
0.352 
Yes -7.6 -16.0 
to 0.9 
3% 
MCHC 
(g/dL) 
ADVIA 
bovine 
Calculated 
MCHC 
from PCV 
155 -
0.03 
-6.604 -27.716 
to 6.433 
No 1.081 0.752 
to 
1.611 
No -3.1 -11.8 
to 5.6 
48% 
MCHC 
(g/dL) 
ADVIA 
goat 
Calculated 
MCHC 
from PCV 
38 0.39 -
49.01
3 
-109.595 
to -
15.474 
Yes 1.887 1.069 
to 
3.377 
Yes -11.6 -24.2 
to 1.2 
0% 
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Figure 7. Comparison of ADVIA platelet counts with a manual platelet estimate  
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Figure 8. Comparison of RBC values between Mhl-positive and Mhl-negative camelids 
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Figure 9. Comparison of spun PCV A) between Mhl-positive and Mhl-negative animals with FEC>600 epg, and B) between Mhl-positive 
animals with CT values<30.0 and Mhl-negative animals 
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Figure 10. Comparison of RBC values between FEC strata (low = <450 epg; 600 = 600<FEC<1000; 1000 = ≥1000 epg) 
 
 
15
20
25
30
35
40
45
50
FEC (epg)
PC
V 
(%
)
1000 600 Low
6
8
10
12
14
16
18
20
FEC (epg)
H
G
B 
co
nc
en
tra
tio
n 
(g
/d
L)
1000 600 Low
6
8
10
12
14
16
18
20
FEC (epg)
H
G
B 
co
nc
en
tra
tio
n 
(g
/d
L)
1000 600 Low
p = 0.009 
* 
* p = 0.0075 
* 
* 
p = 0.105 
88 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 11. Distribution of hemoglobin concentration by FEC 
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Figure 12. ROC curve analysis for HGB and spun PCV, using an FEC threshold of 600 epg 
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